Acetic acid derivatives and related substances

RX_ACETICDERIV

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Medicine purchases: ATC — M01AB 1 out of 7 registries used, show all original rules.	131319
4. Check minimum number of events Min. number of events 3	131319
5. Include endpoints None	131319
6. Filter based on genotype QC (FinnGen only)	119024

Control definitions (FinnGen only)

Control exclude: RX_NSAID

Extra metadata

First used in FinnGen datafreeze: DF4

NAME	RX_ACETICDERIV
CONTROL_EXCLUDE	RX_NSAID
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	M01AB
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Acetic acid derivatives and related substances based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	119024	71130	47894
Unadjusted period prevalence (%)	23.93	25.25	21.96
Median age at first event (years)	44.37	43.14	46.21

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
18113: Matched controls
93593

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

B01AB05

ATC

enoxaparin; parenteral

2.1

323.0

4263

11777

R42

ICD-10 Finland

Dizziness and giddiness

2.3

322.0

3512

8956

L16

ICPC

Ankle symptom/complaint

3.1

316.4

1743

3108

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

8.9

316.0

569

340

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

2.3

314.3

3224

7992

D07AC13

ATC

mometasone; topical

2.1

310.9

4106

11322

GD1AA, ,

SPAT

2.7

308.6

2183

4502

M03BC51

ATC

orphenadrine, combinations; systemic

8.3

307.7

4848

3969

R51.80

ICD-10 Finland

Headache

4.4

307.7

2693

3550

J01CA04

ATC

amoxicillin; systemic

2.5

307.7

13697

51902

M03BX02

ATC

tizanidine; oral

11.2

307.7

11784

13303

M54.9

ICD-10 Finland

Dorsalgia, unspecified

5.7

307.7

2323

2346

N02CC03

ATC

zolmitriptan; nasal, oral

9.2

307.7

648

376

R05FB02

ATC

cough suppressants and expectorants; systemic

2.7

307.7

5564

13379

N02BF01

ATC

gabapentin; oral

6.6

307.7

1565

1328

OAA65, ,

SPAT

2.7

307.7

2740

5710

SAA01

NOMESCO Finland

Simple examination of mouth

1.9

307.7

10970

41615

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

7.4

307.7

803

586

M01AE01

ATC

ibuprofen; systemic, rectal

8.5

307.7

15305

36618

M54.2

ICD-10 Finland

Cervicalgia

6.4

307.7

1245

1063

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.6

307.7

3024

6766

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

5.8

307.7

1081

1014

R03AK07

ATC

formoterol and budesonide; inhalant

3.0

307.7

3115

6132

M54

ICD-10 Finland

Dorsalgia

6.0

307.7

2325

2233

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

6.5

307.7

1023

856

A02BC05

ATC

esomeprazole; systemic

3.7

307.7

6569

12465

G43.9

ICD-10 Finland

Migraine, unspecified

7.5

307.7

984

709

NBL00

NOMESCO Finland

Suture or reinsertation of rotator cuff of shoulder

8.9

307.7

627

377

R06.0

ICD-10 Finland

Dyspnoea

2.3

307.7

4245

10898

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

3.2

307.7

3711

6988

X59

ICD-10 Finland

Exposure to unspecified factor

3.0

307.7

3038

5875

M01AB08

ATC

etodolac; oral

25.0

307.7

1383

309

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.8

307.7

4013

8715

N05BA04

ATC

oxazepam; oral

2.4

307.7

4205

10365

M01AB51

ATC

indometacin, combinations; oral, rectal

26.4

307.7

493

N02BE01

ATC

paracetamol; systemic, rectal

6.1

307.7

15605

47120

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

7.4

307.7

1490

1118

M01AG02

ATC

tolfenamic acid; oral, rectal

10.9

307.7

1861

976

R05DA20

ATC

opium alkaloids and derivatives - combinations

2.5

307.7

3799

9138

L90

ICPC

Osteoarthrosis of knee

6.4

307.7

762

633

A02BA02

ATC

ranitidine; systemic

2.7

307.7

2839

5978

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

11.6

307.7

1536

741

N02BF02

ATC

pregabalin; oral

6.2

307.7

1056

932

N02AJ06

ATC

codeine and paracetamol; systemic

5.8

307.7

7617

10463

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

10.5

307.7

1227

646

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

2.5

307.7

8157

23297

N02CC04

ATC

rizatriptan; oral

8.9

307.7

668

401

N06AX21

ATC

duloxetine; oral

5.9

307.7

1877

1804

N06AX11

ATC

mirtazapine; oral

2.8

307.7

5507

12672

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.3

307.7

6108

16732

R07.4

ICD-10 Finland

Chest pain, unspecified

2.6

307.7

4219

9916

H02BX01

ATC

methylprednisolone, combinations; systemic

8.2

307.7

742

483

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

6.2

307.7

879

768

M19.0

ICD-10 Finland

Primary arthrosis of other joints

8.1

307.7

1370

932

J01MA02

ATC

ciprofloxacin; systemic

2.3

307.7

6247

17551

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

10.1

307.7

891

479

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

9.0

307.7

926

558

M79.7

ICD-10 Finland

Fibromyalgia

13.9

307.7

461

176

M01AE03

ATC

ketoprofen; systemic, rectal

8.3

307.7

6278

5628

M02AA07

ATC

piroxicam; topical

6.5

307.7

6336

7118

M75.1

ICD-10 Finland

Rotator cuff syndrome

6.6

307.7

4107

3964

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.6

307.7

8498

23484

WX320

NOMESCO Finland

Spinalanesthesy

2.9

307.7

3520

7273

M01AX05

ATC

glucosamine; oral

24.0

307.7

2804

710

H02AB06

ATC

prednisolone; systemic

2.7

307.7

7944

20751

L86

ICPC

Back syndrome with radiating pain

7.5

307.7

978

703

M16.1

ICD-10 Finland

Other primary coxarthrosis

6.1

307.7

1657

1510

J01AA02

ATC

doxycycline; systemic

3.8

307.7

13125

38567

M53.0

ICD-10 Finland

Cervicocranial syndrome

5.6

307.7

1405

1387

M01AB55

ATC

diclofenac, combinations; oral

33.8

307.7

1651

277

M01AB16

ATC

aceclofenac; oral

29.3

307.7

529

M01AC06

ATC

meloxicam; systemic, rectal

16.0

307.7

5992

2797

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

17.0

307.7

526

164

G43

ICD-10 Finland

Migraine

8.4

307.7

871

560

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

11.7

307.7

861

396

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

10.4

307.7

2522

1432

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

2.1

307.7

6757

21014

M53.1

ICD-10 Finland

Cervicobrachial syndrome

6.2

307.7

1855

1685

A02BC03

ATC

lansoprazole; oral

3.2

307.7

4409

8461

M77.1

ICD-10 Finland

Lateral epicondylitis

7.9

307.7

1101

756

WX110

NOMESCO Finland

Infiltration anesthesia

2.0

307.7

11206

42487

J01FA06

ATC

roxithromycin; oral

2.6

307.7

6007

14920

R06AE07

ATC

cetirizine; oral

2.4

307.7

6735

18519

A02BC01

ATC

omeprazole; systemic

2.8

307.7

4509

10056

J01CE02

ATC

phenoxymethylpenicillin; oral

2.3

307.7

10884

37430

M17.1

ICD-10 Finland

Other primary gonarthrosis

7.8

307.7

3184

2480

M25.5

ICD-10 Finland

Pain in joint

5.6

307.7

5517

6814

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.2

307.7

5098

14169

R74

ICPC

Upper respiratory infection acute

2.1

307.7

4997

14266

C07AA05

ATC

propranolol; systemic

2.5

307.7

2873

6556

M09AX01

ATC

hyaluronic acid; parenteral

15.9

307.7

769

261

M01AH01

ATC

celecoxib; oral

19.9

307.7

2986

920

M79.1

ICD-10 Finland

Myalgia

4.9

307.7

2546

3019

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

7.4

307.7

885

643

ZXD10

NOMESCO Finland

Scheduled procedure

2.2

307.7

5578

15768

P01BA02

ATC

hydroxychloroquine; oral

5.4

307.7

958

953

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

4.7

307.7

1266

1458

N03AX12

ATC

[U] gabapentin; oral

7.5

307.7

2692

2123

M02AA15

ATC

diclofenac; topical

8.4

307.7

1122

726

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.4

307.7

4142

10479

ACC51

NOMESCO Finland

Release of median nerve

6.5

307.7

898

740

R01BA52

ATC

pseudoephedrine, combinations; oral

3.1

307.7

3773

7362

N06AX16

ATC

venlafaxine; oral

3.1

307.7

2034

3644

J01FF01

ATC

clindamycin; systemic

2.6

307.7

4092

9431

M01AB01

ATC

indometacin; systemic, rectal

23.0

307.7

2403

617

S83.2

ICD-10 Finland

Tear of meniscus, current

5.9

307.7

921

844

X58

ICD-10 Finland

Exposure to other specified factors

3.3

307.7

2348

4054

ZXE10

NOMESCO Finland

More than one and less than three hours

2.3

307.7

5219

14181

M54.3

ICD-10 Finland

Sciatica

7.4

307.7

843

611

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

8.5

307.7

2111

1430

N02AX02

ATC

tramadol; systemic, rectal

6.8

307.7

8555

10945

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

2.0

307.7

8047

26826

L13

ICPC

Hip symptom/complaint

4.0

307.7

2665

3829

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

5.2

307.7

1796

1957

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

6.0

307.7

1377

1264

J02AC01

ATC

fluconazole; systemic

2.5

307.7

5100

12481

N05CF02

ATC

zolpidem; oral

3.7

307.7

2515

3892

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

7.2

307.7

2144

1705

R01AD12

ATC

fluticasone furoate; nasal

2.9

307.7

4555

9802

N06AA09

ATC

amitriptyline; systemic

6.0

307.7

1430

1318

F51.0

ICD-10 Finland

Nonorganic insomnia

3.1

307.7

2728

5078

G44.2

ICD-10 Finland

Tension-type headache

5.0

307.7

2165

2470

G56.0

ICD-10 Finland

Carpal tunnel syndrome

5.9

307.7

1939

1864

G47.3

ICD-10 Finland

Sleep apnoea

2.8

307.7

3136

6602

M01AC01

ATC

piroxicam; systemic, rectal

10.0

307.7

1884

1074

S18

ICPC

Laceration/cut

2.2

307.7

7050

20749

J01.0

ICD-10 Finland

Acute maxillary sinusitis

3.2

307.7

3768

7138

L04AX03

ATC

methotrexate; systemic

4.6

307.7

1247

1474

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

12.5

307.7

771

333

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

7.3

307.7

8316

9734

M01AH02

ATC

rofecoxib; oral

15.5

307.7

2006

747

P01AB01

ATC

metronidazole; oral, rectal

2.5

307.7

5750

14889

L15

ICPC

Knee symptom/complaint

3.9

307.7

3755

5893

A01

ICPC

Pain general/multiple sites

3.9

307.7

1562

2237

J01FA09

ATC

clarithromycin; systemic

3.1

307.7

4547

9201

J01FA10

ATC

azithromycin; systemic

2.9

307.7

9193

24411

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.9

307.7

1424

2001

M79.6

ICD-10 Finland

Pain in limb

4.3

307.7

7477

13034

N06CA01

ATC

amitriptyline and psycholeptics; systemic

5.0

307.7

1418

1569

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

307.7

7125

23285

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

10.5

307.7

840

431

R01AD08

ATC

fluticasone; nasal

2.7

307.7

4251

9431

M48.0

ICD-10 Finland

Spinal stenosis

7.1

307.7

2028

1637

R06AX22

ATC

ebastine; oral

2.8

307.7

2292

4659

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

8.4

307.7

634

403

L12

ICPC

Hand/finger symptom/complaint

2.9

307.7

2570

4987

M54.6

ICD-10 Finland

Pain in thoracic spine

5.1

307.7

1134

1211

L17

ICPC

Foot/toe symptom/complaint

2.7

307.7

4647

10769

M04AA01

ATC

allopurinol; systemic

2.8

307.7

2324

4680

M70.6

ICD-10 Finland

Trochanteric bursitis

7.4

307.7

1723

1313

R05FA02

ATC

opium derivatives and expectorants; systemic

2.6

307.7

6091

15225

M01AH05

ATC

etoricoxib; oral

20.0

307.7

11268

7105

M01AE11

ATC

tiaprofenic acid; oral, rectal

15.3

307.7

568

197

N01

ICPC

Headache

3.0

307.7

1866

3415

A02BC02

ATC

pantoprazole; systemic

3.9

307.7

11800

30146

M01AX01

ATC

nabumetone; oral

18.0

307.7

535

158

N89

ICPC

Migraine

8.2

307.7

647

423

R06AX27

ATC

desloratadine; oral

2.8

307.7

4230

9306

R10.1

ICD-10 Finland

Pain localized to upper abdomen

3.0

307.7

2660

5112

ZXE00

NOMESCO Finland

One hour or less

2.1

307.7

5884

17653

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

5.6

307.7

1154

1115

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

4.7

307.7

1612

1898

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.8

307.7

6126

14435

ZXA00

NOMESCO Finland

Right side

2.4

307.7

3736

9062

N02CC07

ATC

frovatriptan; oral

11.7

307.7

521

237

R01AD09

ATC

mometasone; nasal

3.1

307.7

7177

16498

M54.4

ICD-10 Finland

Lumbago with sciatica

8.4

307.7

3237

2370

L08

ICPC

Shoulder symptom/complaint

4.2

307.7

3534

5144

R03AC02

ATC

salbutamol; inhalant

2.7

307.7

8910

24542

M01AE02

ATC

naproxen; oral, rectal

11.5

307.7

10360

9763

L01

ICPC

Neck symptom/complaint

3.9

307.7

2565

3785

A07EC01

ATC

sulfasalazine; oral, rectal

7.6

307.7

1224

881

R01AD58

ATC

fluticasone, combinations; nasal

3.2

307.7

3765

7089

M02AA10

ATC

ketoprofen; topical

6.2

307.7

2557

2399

D07AC01

ATC

betamethasone; topical

2.1

307.7

5314

15745

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

4.3

307.7

2442

3283

M01AX17

ATC

nimesulide; oral

12.3

307.7

3839

1996

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

7.3

307.7

773

569

J01DA01

ATC

[U] cefalexin

2.6

307.7

10310

31343

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

7.8

307.7

1763

1269

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

2.1

307.7

4529

12647

NA3BG, ,

SPAT

8.4

307.7

604

381

M01AB05

ATC

diclofenac; systemic, rectal

117.7

307.7

17017

10904

N05CF01

ATC

zopiclone; oral

2.7

307.7

5327

12679

L03

ICPC

Low back symptom/complaint

4.4

307.7

5083

7702

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

7.0

307.7

957

741

R52.9

ICD-10 Finland

Pain, unspecified

3.7

307.7

1584

2346

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

7.3

307.7

1441

1102

ZXA05

NOMESCO Finland

Left side

2.4

307.7

3465

8499

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

12.2

307.7

736

325

J01DB01

ATC

cefalexin; oral

3.2

307.7

13987

48107

M01AH03

ATC

valdecoxib; oral

19.2

307.7

733

205

R03DC03

ATC

montelukast; oral

2.8

307.7

2190

4379

NG1AA, ,

SPAT

5.2

307.7

924

964

A06AC01

ATC

ispaghula (psylla seeds); oral

2.9

307.7

3905

8005

M03BC01

ATC

orphenadrine (citrate); systemic

11.1

307.7

4323

2562

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

5.4

307.7

1580

1636

M01AC02

ATC

tenoxicam; systemic, rectal

9.7

307.7

581

319

L02

ICPC

Back symptom/complaint

3.9

307.7

1664

2354

N03AX16

ATC

[U] pregabalin

6.8

307.7

4122

3863

M54.5

ICD-10 Finland

Low back pain

5.9

307.7

6871

8802

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.9

307.5

6083

19455

N02CC06

ATC

eletriptan; oral

12.8

305.9

451

186

M15

ICD-10 Finland

Polyarthrosis

7.8

305.4

600

409

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.3

303.8

3108

7684

R53

ICD-10 Finland

Malaise and fatigue

2.1

302.3

4170

11680

J01DA09

ATC

[U] cefadroxil

2.1

302.0

3870

10527

G04CA01

ATC

alfuzosin; oral

2.7

301.6

2095

4275

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

6.0

300.5

726

645

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.1

300.3

4256

12042

A02BC04

ATC

rabeprazole; oral

4.1

298.6

1090

1445

N05BA01

ATC

diazepam; systemic, rectal

2.8

296.9

1970

3917

M01AE52

ATC

naproxen and esomeprazole; oral

20.8

296.8

364

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

8.5

296.6

550

344

R4110

NOMESCO Finland

Physiotherapy

2.1

296.5

4021

11176

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

8.8

296.1

538

326

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

2.1

294.4

4244

12074

N02CC05

ATC

almotriptan; oral

10.5

288.2

470

237

R05

ICD-10 Finland

Cough

2.3

285.6

2899

7125

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

6.6

285.4

640

520

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

11.3

281.5

441

206

E0000UV, ,

ATC

1.9

280.6

6161

20260

R51

ICD-10 Finland

Headache

4.6

280.3

886

1036

E66.01

ICD-10 Finland

Obesity due to excess calories

3.4

277.7

1285

2036

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

4.2

277.4

977

1256

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

5.6

273.1

699

662

R05

ICPC

Cough

2.1

272.0

3475

9394

M75

ICD-10 Finland

Shoulder lesions

6.5

270.6

607

493

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.4

270.1

2371

5437

N06AB10

ATC

escitalopram; oral

2.2

269.8

3032

7772

D07AB02

ATC

hydrocortisone butyrate; topical

2.0

269.7

4216

12306

S01GX01

ATC

cromoglicic acid; ophthalmic

2.3

269.2

2624

6318

M13.9

ICD-10 Finland

Arthritis, unspecified

4.1

268.9

974

1281

Z3226

NOMESCO Finland

Physiotherapist

2.3

268.2

2612

6286

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

9.0

267.4

478

282

C05AA08

ATC

fluocortolone; rectal, topical

2.8

266.4

1716

3346

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

16.2

266.3

356

116

R52.2

ICD-10 Finland

Other chronic pain

7.5

266.1

536

378

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

14.1

265.7

375

140

C09CA06

ATC

candesartan; oral

2.2

265.0

3200

8446

M76.6

ICD-10 Finland

Achilles tendinitis

5.7

263.5

665

620

OAB91, ,

SPAT

3.9

262.4

1027

1437

L01BA01

ATC

methotrexate; systemic

9.8

260.8

443

240

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

3.3

259.8

1251

2035

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

6.1

259.0

614

533

J20

ICD-10 Finland

Acute bronchitis

3.1

257.8

1417

2512

N02AA05

ATC

oxycodone; systemic

2.3

257.6

2757

6909

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

15.0

257.4

354

124

L28

ICPC

Limited function/disability (L)

2.2

257.4

2801

7070

G04CA02

ATC

tamsulosin; oral

2.0

257.2

4131

12147

D01

ICPC

Abdominal pain/cramps general

2.6

254.6

1862

3888

N06AB04

ATC

citalopram; systemic

2.2

254.5

2929

7567

A03FA01

ATC

metoclopramide; systemic, rectal

2.2

254.1

2978

7751

J05AB01

ATC

aciclovir; systemic

2.2

252.7

2925

7573

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

5.3

252.0

686

693

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.9

251.3

5334

17218

WX408

NOMESCO Finland

General anesthesy, balanced

2.1

250.3

3506

9788

P06

ICPC

Sleep disturbance

2.6

248.7

1910

4089

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

12.3

248.0

372

159

L84

ICPC

Back syndrome without radiat pain

5.0

247.9

711

757

M45

ICD-10 Finland

Ankylosing spondylitis

16.7

247.7

327

103

M47.82

ICD-10 Finland

Other spondylosis, cervical region

7.9

247.5

479

319

K30

ICD-10 Finland

Functional dyspepsia

2.9

247.5

1511

2852

M54.8

ICD-10 Finland

Other dorsalgia

5.2

244.7

674

689

M54.1

ICD-10 Finland

Radiculopathy

7.2

244.6

506

370

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

12.3

244.5

367

157

R4110, ,

SPAT

2.8

244.2

1618

3199

L11

ICPC

Wrist symptom/complaint

3.1

243.2

1334

2359

M77.4

ICD-10 Finland

Metatarsalgia

4.7

240.6

734

829

K10.3

ICD-10 Finland

Alveolitis of jaws

5.1

240.6

676

705

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

3.2

240.4

1247

2128

S80.0

ICD-10 Finland

Contusion of knee

3.5

240.3

1084

1683

D01BA02

ATC

terbinafine; oral

2.0

239.2

3444

9697

M23.8

ICD-10 Finland

Other internal derangements of knee

7.5

239.1

482

340

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

4.9

238.3

696

754

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.9

236.0

4287

13100

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

3.3

235.5

1152

1891

M79.0

ICD-10 Finland

Rheumatism, unspecified

11.4

234.6

365

168

R03BA05

ATC

fluticasone; inhalant

2.2

234.1

2575

6508

J45.9

ICD-10 Finland

Asthma, unspecified

2.2

233.7

2677

6882

WX290

NOMESCO Finland

Other blockage of nerve

1.7

233.1

6917

24577

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

9.1

233.1

413

240

OAB93, ,

SPAT

3.8

230.4

914

1290

D11

ICPC

Diarrhoea

2.5

229.7

1815

3935

SPAT1153

SPAT

Removal of sutures

1.9

229.6

4007

12062

N05BA12

ATC

alprazolam; oral

3.0

228.1

1314

2392

G04BD12

ATC

mirabegron; oral

2.8

227.4

1487

2914

SFA20

NOMESCO Finland

Two-surface restoration

1.7

227.3

8322

31282

NA3AA, ,

SPAT

6.5

227.3

510

414

N02AC04

ATC

dextropropoxyphene; oral

5.1

226.1

640

672

N05AH04

ATC

quetiapine; oral

2.1

225.6

2838

7569

R07.3

ICD-10 Finland

Other chest pain

2.9

224.7

1395

2654

SPAT1212

SPAT

Extensive examination of musculoskeletal system

3.4

221.5

1030

1632

WX002

NOMESCO Finland

Sedation and analgesia

2.2

221.0

2533

6501

S93.4

ICD-10 Finland

Sprain and strain of ankle

2.6

220.6

1590

3284

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.3

217.5

2198

5344

J01DA06

ATC

[U] cefuroxime

2.4

217.4

1916

4376

M01AG01

ATC

mefenamic acid; oral

16.3

217.1

289

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

5.7

215.6

546

510

NF1AA

NOMESCO Finland

Hip X-ray examination

3.1

215.4

1166

2041

I10

ICD-10 Finland

Essential (primary) hypertension

1.7

214.9

8712

33470

Z01.8

ICD-10 Finland

Other specified special examinations

2.0

211.7

3117

8806

J01MA12

ATC

levofloxacin; systemic

2.1

210.6

2722

7320

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.2

209.8

2441

6294

J01FA15

ATC

telithromycin; oral

3.2

209.3

1080

1833

SFA30

NOMESCO Finland

Three-surface restoration

1.7

206.9

5497

18767

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

4.2

206.2

718

911

ZXD20

NOMESCO Finland

Day surgery

2.6

206.2

1573

3342

R06AE09

ATC

levocetirizine; oral

2.4

206.0

1785

4039

H02AB04

ATC

methylprednisolone; systemic

2.3

203.5

1964

4670

H02AB07

ATC

prednisone; oral

2.3

203.2

1910

4487

SFA10

NOMESCO Finland

One-surface restoration

1.6

203.2

7977

30233

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

202.8

4257

13532

L88

ICPC

Rheumatoid/seropositive arthritis

6.4

202.5

459

377

N04BC05

ATC

pramipexole; oral

3.4

202.4

937

1478

EMB10

NOMESCO Finland

Tonsillectomy

4.0

201.5

742

986

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

4.7

201.5

615

694

Z71.8

ICD-10 Finland

Other specified counselling

1.8

200.8

4963

16565

Z01.2

ICD-10 Finland

Dental examination

1.7

200.5

6547

23617

M19.8

ICD-10 Finland

Other specified arthrosis

6.3

199.9

459

383

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

5.2

199.4

546

554

G43.3

ICD-10 Finland

Complicated migraine

18.6

198.4

252

D07AD01

ATC

clobetasol; topical

2.3

198.3

2027

4941

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

6.0

198.1

475

417

A03CA02

ATC

clidinium and psycholeptics; oral

4.0

196.7

730

976

NB1AA, ,

SPAT

5.7

196.0

492

455

J01

ICD-10 Finland

Acute sinusitis

4.0

195.7

730

980

R21

ICPC

Throat symptom/complaint

1.9

195.5

3183

9293

M22.4

ICD-10 Finland

Chondromalacia patellae

8.0

194.2

374

247

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

2.8

193.1

1245

2414

M10.9

ICD-10 Finland

Gout, unspecified

3.1

192.8

1042

1819

L29

ICPC

Musculoskeletal sympt/complt other

2.9

192.3

1172

2200

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.6

191.7

1375

2825

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.9

191.4

3477

10525

R02

ICPC

Shortness of breath/dyspnoea

2.3

191.1

1944

4724

J35.0

ICD-10 Finland

Chronic tonsillitis

4.1

191.0

681

881

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

3.8

190.7

763

1082

J02AC02

ATC

itraconazole; systemic

2.2

190.6

1984

4869

H04.10

ICD-10 Finland

Dry eye syndrome

2.6

189.8

1403

2928

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

3.3

189.6

934

1536

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

3.2

189.5

950

1580

M19.9

ICD-10 Finland

Arthrosis, unspecified

5.8

189.4

469

427

R03BA02

ATC

budesonide; inhalant

2.1

189.4

2410

6421

U07.2

ICD-10 Finland

COVID-19, virus not identified

2.0

189.1

2838

8041

Z2221

NOMESCO Finland

Medical doctor

1.8

189.1

3959

12533

M47.9

ICD-10 Finland

Spondylosis, unspecified

7.3

189.0

386

277

J01MA06

ATC

norfloxacin; oral

2.4

187.8

1623

3660

S22.3

ICD-10 Finland

Fracture of rib

3.1

187.7

994

1713

NG1BG, ,

SPAT

5.1

186.5

519

535

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

7.1

186.1

389

288

R5140

NOMESCO Finland

Monitoring the use of the aid

2.6

185.9

1413

2991

R01AD01

ATC

beclometasone; nasal

2.3

185.4

1811

4320

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

9.5

185.3

318

175

B01AX06

ATC

[U] rivaroxaban

14.5

184.3

257

M75.2

ICD-10 Finland

Bicipital tendinitis

9.7

184.2

312

168

R06AX13

ATC

loratadine; oral

2.2

184.1

1912

4684

J01EA01

ATC

trimethoprim; systemic

1.8

182.7

3519

10837

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.9

182.5

2949

8566

R12

ICD-10 Finland

Heartburn

2.9

181.9

1103

2063

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

3.3

181.5

880

1431

E66.8

ICD-10 Finland

Other obesity

3.9

181.0

690

942

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

9.1

180.2

319

185

M75.8

ICD-10 Finland

Other shoulder lesions

5.3

179.9

483

480

NBG10

NOMESCO Finland

Acromioplastia

9.4

179.8

312

175

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

9.4

178.9

309

172

H01

ICPC

Ear pain/earache

2.3

178.7

1644

3814

M43.1

ICD-10 Finland

Spondylolisthesis

6.4

178.5

404

331

C10AA07

ATC

rosuvastatin; oral

1.8

178.1

3915

12547

H92.0

ICD-10 Finland

Otalgia

3.3

177.5

858

1392

D06

ICPC

Abdominal pain localized other

2.7

176.5

1234

2498

R05DA01

ATC

ethylmorphine; oral

3.0

176.5

975

1724

M65.9

ICD-10 Finland

Synovitis and tenosynovitis, unspecified

7.1

175.2

365

269

WZA00

NOMESCO Finland

Concise certificate

3.2

175.0

874

1449

K02.1

ICD-10 Finland

Caries of dentine

1.6

174.9

8697

34483

C07AB07

ATC

bisoprolol; oral

1.6

173.6

7134

27007

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

14.6

172.8

240

NG2AA

NOMESCO Finland

Patella X-ray examination

7.9

172.0

332

220

L03.0

ICD-10 Finland

Cellulitis of finger and toe

2.7

171.5

1179

2364

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.7

171.3

4718

16103

KMAK, ,

NOMESCO Finland

1.6

171.2

7121

27011

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.3

171.1

1645

3890

OAB43, ,

SPAT

1.7

170.4

4262

14157

3007

Kela drug reimbursment

Erenumab and fremanezumab

28.0

170.4

193

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

2.6

170.3

1263

2636

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

8.8

170.1

306

182

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

12.0

169.9

258

113

NBF25

NOMESCO Finland

Operation for humeroscapular osteochondritis, arthroscopic

12.1

169.4

256

111

R60.0

ICD-10 Finland

Localized oedema

2.3

168.8

1703

4113

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

14.6

168.4

234

NF1AA, ,

SPAT

5.3

168.3

450

445

N40

ICD-10 Finland

Hyperplasia of prostate

1.8

168.3

3596

11400

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.9

168.0

2846

8379

M77.0

ICD-10 Finland

Medial epicondylitis

9.0

167.6

298

174

N06AB03

ATC

fluoxetine; oral

2.3

166.5

1541

3580

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.8

166.3

3447

10823

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

4.6

165.8

515

590

E66

ICD-10 Finland

Obesity

3.7

165.2

682

989

L10

ICPC

Elbow symptom/complaint

3.5

165.0

734

1124

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

18.1

164.6

211

S06.0

ICD-10 Finland

Concussion

2.3

163.9

1594

3786

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

3.8

163.7

637

883

ND2AA, ,

SPAT

3.9

163.7

628

861

UJF32

NOMESCO Finland

Coloscopy

1.8

163.5

3417

10748

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.3

162.8

1527

3568

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

8.0

161.3

310

204

7151F

ICD-9 Finland

Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]

6.3

161.3

371

310

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

160.9

2557

7356

M65.4

ICD-10 Finland

Radial styloid tenosynovitis [de Quervain]

6.6

160.2

356

285

J31.0

ICD-10 Finland

Chronic rhinitis

2.8

160.2

1035

2004

L04AA13

ATC

[U] leflunomide

11.3

160.0

250

116

R20.2

ICD-10 Finland

Paraesthesia of skin

3.0

159.4

907

1631

N05CD07

ATC

temazepam; oral

2.2

159.1

1779

4482

N02AJ13

ATC

tramadol and paracetamol; systemic

9.3

158.9

276

155

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

13.6

157.9

226

G54.0

ICD-10 Finland

Brachial plexus disorders

7.5

157.8

315

219

G56.2

ICD-10 Finland

Lesion of ulnar nerve

5.5

157.2

411

397

L05

ICPC

Flank/axilla symptom/complaint

3.1

156.8

842

1461

WZA90

NOMESCO Finland

Other medical or dental certificate

1.8

156.5

3044

9351

R35

ICD-10 Finland

Polyuria

2.8

156.5

974

1846

R07.0

ICD-10 Finland

Pain in throat

2.8

156.2

988

1890

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.1

156.1

1856

4792

DM1QA, ,

SPAT

4.3

155.8

529

656

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.7

155.3

3635

11802

L04AB01

ATC

etanercept; parenteral

19.8

155.1

193

K08.80

ICD-10 Finland

Toothache NOS

2.6

155.0

1118

2297

R06.5

ICD-10 Finland

Mouth breathing

2.7

154.9

1054

2099

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

154.4

9816

40685

SPAT1283

SPAT

Restricted health certificate

1.9

154.3

2420

6922

NH3AA, ,

SPAT

3.7

154.2

616

871

R03AC03

ATC

terbutaline; inhalant

2.1

154.0

1775

4525

Z3231

NOMESCO Finland

Registered nurse

1.7

153.7

3917

13022

M20.1

ICD-10 Finland

Hallux valgus (acquired)

3.3

153.5

750

1224

N17

ICPC

Vertigo/dizziness

2.2

152.6

1717

4333

N06AA10

ATC

nortriptyline; systemic

11.1

152.4

240

113

S29

ICPC

Skin symptom/complaint other

1.8

151.6

2777

8361

M65.3

ICD-10 Finland

Trigger finger

4.5

151.2

481

563

J45

ICD-10 Finland

Asthma

2.4

150.9

1292

2890

R01AD59

ATC

mometasone, combinations; nasal

3.0

150.8

821

1436

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

3.8

149.3

594

837

A02BA04

ATC

nizatidine; systemic

2.7

149.2

1011

2008

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.7

148.8

980

1916

M67.4

ICD-10 Finland

Ganglion

3.1

148.8

807

1408

R01AD11

ATC

triamcinolone; nasal

2.7

148.5

996

1967

A03FA02

ATC

cisapride; oral, rectal

2.7

148.0

990

1952

NBG00

NOMESCO Finland

Plastic operation on acromioclavicular joint

21.7

148.0

179

M77.9

ICD-10 Finland

Enthesopathy, unspecified

5.5

147.9

386

372

SGA01

NOMESCO Finland

Emergency treatment

2.0

147.8

2061

5648

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

5.1

146.8

410

424

J01CA08

ATC

pivmecillinam; oral

1.6

146.7

4956

17705

J01MA01

ATC

ofloxacin; systemic

2.5

146.7

1131

2403

M01AE51

ATC

ibuprofen, combinations; systemic

17.6

146.2

189

ZXA10

NOMESCO Finland

Bilateral

1.9

145.2

2410

7017

WX402

NOMESCO Finland

General anaesthesia

1.8

144.6

2822

8656

M10.0

ICD-10 Finland

Idiopathic gout

4.0

144.3

527

694

SPAT1263

SPAT

Sampling

1.6

144.2

5983

22430

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

10.5

144.0

234

117

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

5.0

143.7

411

435

D07CC01

ATC

betamethasone and antibiotics; topical

2.2

143.7

1546

3826

N41.1

ICD-10 Finland

Chronic prostatitis

6.0

143.4

343

300

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

7.1

143.2

299

221

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.0

143.0

2018

5550

L14

ICPC

Leg/thigh symptom/complaint

2.6

142.7

1042

2152

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

2.4

142.6

1229

2756

G04BD08

ATC

solifenacin; oral

3.0

142.6

794

1408

WX111

NOMESCO Finland

Local infiltration anesthesia

6.5

142.5

318

256

K07.60

ICD-10 Finland

Snapping jaw

3.5

141.2

607

906

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

9.1

141.1

248

142

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

141.0

4988

17988

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.1

140.9

1597

4036

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.0

140.8

1947

5314

NGF00

NOMESCO Finland

Excision of plica of synovy of knee

10.2

140.7

232

119

A06AD11

ATC

lactulose; oral

1.9

140.7

2359

6886

M75.5

ICD-10 Finland

Bursitis of shoulder

7.9

140.5

272

181

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.7

140.3

3860

13057

M76.0

ICD-10 Finland

Gluteal tendinitis

10.1

140.1

232

120

A06AC51

ATC

ispaghula, combinations; oral

3.7

139.9

576

833

U02

ICPC

Urinary frequency/urgency

2.0

139.9

1876

5062

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.4

139.8

1167

2576

D07CA01

ATC

hydrocortisone and antibiotics; topical

2.1

139.4

1608

4092

K04.08

ICD-10 Finland

Other specified pulpit

2.5

139.0

1056

2225

A11

ICPC

Chest pain NOS

2.5

138.5

1054

2223

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

138.4

1795

4782

NA1BG, ,

SPAT

10.1

137.9

229

119

UKC02

NOMESCO Finland

Cystoscopy

1.9

137.7

2390

7053

C10AA05

ATC

atorvastatin; oral

1.6

137.3

5428

20069

F45.8

ICD-10 Finland

Other somatoform disorders

2.8

137.0

845

1591

L09

ICPC

Arm symptom/complaint

3.4

136.7

615

948

AA1AD

NOMESCO Finland

CT of head and brain

1.6

136.2

3985

13683

XKD00

NOMESCO Finland

Uroflowmetry

1.9

135.6

2348

6921

H60.9

ICD-10 Finland

Otitis externa, unspecified

2.5

135.3

1044

2217

M10

ICD-10 Finland

Gout

3.5

134.9

594

902

R03BA08

ATC

ciclesonide; inhalant

2.6

134.6

979

2017

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

13.0

134.0

195

J05AB11

ATC

valaciclovir; oral

2.0

133.9

1716

4548

OAA81, ,

SPAT

4.0

133.7

487

640

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

3.1

133.6

702

1200

A98

ICPC

Health maint/preventive medicine

1.7

133.4

15554

72747

N03AX11

ATC

topiramate; oral

6.3

132.9

305

254

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

14.3

132.8

186

B01AF01

ATC

rivaroxaban; oral

2.2

132.1

1442

3585

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.0

132.1

1957

5468

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

6.2

131.9

308

262

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

3.1

131.7

700

1205

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.1

131.1

1668

4407

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

6.3

130.8

298

246

N06AX12

ATC

bupropion; oral

2.6

130.7

967

2009

NB1AE, ,

SPAT

6.5

130.5

291

234

R03BA01

ATC

beclometasone; inhalant

2.0

130.3

1752

4725

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

3.7

130.1

520

735

W00

ICD-10 Finland

Fall on same level involving ice and snow

2.2

129.7

1430

3569

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

6.4

129.5

292

238

J34.2

ICD-10 Finland

Deviated nasal septum

3.3

129.4

616

987

L04

ICPC

Chest symptom/complaint

2.7

129.0

838

1624

R06AX26

ATC

fexofenadine; oral

2.9

129.0

760

1393

S83.5

ICD-10 Finland

Sprain and strain involving (anterior)(posterior) cruciate ligament of knee

4.3

128.9

431

527

C08CA01

ATC

amlodipine; oral

1.6

128.6

5193

19232

N03AE01

ATC

clonazepam; systemic

3.0

128.4

708

1247

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

2.3

128.4

1188

2749

M17.3

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019198) Lymphocytes [#/volume] in Blood

8824

31676

1.86

316.92

6.4

6.9

1.91

1.85

e9/l

4.93

7772

27774

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

10961

42253

1.86

313.60

3.6

2.9

47.33

46.24

u/l

0.53

10359

39687

(3018010) Neutrophils/Leukocytes in Blood

8224

28974

1.85

311.18

6.3

6.9

57.54

58.60

12.26

7820

27811

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

15180

61883

2.65

307.65

18.7

15.5

23.79

27.96

mg/l

39.25

13185

48655

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

3315

5047

3.93

307.65

1.3

1.2

11.55

11.51

u/ml

0.01

1283

1763

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

13804

57051

2.05

307.65

6.5

5.8

39.12

39.19

mmol/mol

0.35

12963

53210

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

11901

46787

1.92

307.65

4.5

3.8

14.74

14.83

pmol/l

3.04

10930

42462

(3006315) Basophils [#/volume] in Blood

8665

30741

1.88

307.65

6.3

6.9

0.04

e9/l

2.79

7425

26372

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

8742

30857

1.90

307.65

6.0

6.9

11.44

12.70

umol/l

13.21

8274

29362

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

14245

58724

2.19

307.65

17.4

15.4

83.36

81.59

ml/min/173m2

14.43

13267

52742

(3019550) Sodium [Moles/volume] in Serum or Plasma

14994

63396

2.29

307.65

20.7

19.1

139.58

139.52

mmol/l

1.88

14732

61596

(3026493) Urate [Moles/volume] in Serum or Plasma

4925

12311

2.47

307.65

2.7

3.3

346.49

361.14

umol/l

15.34

4322

10991

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

13859

57380

2.06

307.65

5.6

4.5

1.83

2.01

mu/l

21.64

12848

52989

(3001604) Monocytes [#/volume] in Blood

8640

30670

1.87

307.65

6.3

6.9

0.60

e9/l

0.50

7392

26295

(3023103) Potassium [Moles/volume] in Serum or Plasma

15021

63513

2.30

307.65

20.9

19.3

3.98

3.97

mmol/l

8.13

14733

61575

(3013650) Neutrophils [#/volume] in Blood by Automated count

9559

34521

1.91

307.65

8.7

11.3

4.27

4.31

e9/l

0.70

8213

29841

(3037467) Urinalysis macro (dipstick) panel - Urine

11385

42031

2.08

307.65

5.0

4.4

2.42

2.07

0.16

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3575

5738

3.77

307.65

1.4

1.2

26.51

34.84

iu/ml

2.69

991

1654

(3031040) Bacteria [#/volume] in Urine by Automated count

10919

40551

1.99

307.65

5.4

4.4

1007.48

1537.57

e6/l

0.52

160

719

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

4110

10626

2.29

307.65

1.8

2.1

1.15

1.75

mg/l

11.97

3150

8263

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

12208

45275

2.21

307.65

8.1

8.5

78.60

81.63

u/l

6.25

11590

42842

(3013115) Eosinophils [#/volume] in Blood

8916

31623

1.90

307.65

6.4

7.4

0.20

0.19

e9/l

1.30

7777

27497

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

12051

40563

2.60

307.65

4.8

3.5

11.54

13.15

mm/h

23.58

11315

37518

(3019069) Monocytes/Leukocytes in Blood

8162

28767

1.85

307.12

6.6

7.2

8.78

8.90

2.71

7625

27064

(3006504) Eosinophils/Leukocytes in Blood

8146

28707

1.85

306.40

6.5

7.1

2.83

2.73

2.83

7610

27031

(3044889) 12 lead EKG panel

10536

40288

1.84

305.44

4.1

4.0

0.30

9201.12

0.79

(40768797) Stomach Pathology biopsy report

2593

5880

2.49

304.80

1.3

—

(3022096) Basophils/Leukocytes in Blood

8138

28748

1.84

302.53

6.6

7.2

0.65

0.64

1.68

7595

27015

(3009261) Glucose [Presence] in Urine by Test strip

8961

32640

1.83

302.02

4.1

3.8

0.01

0.50

estimate

1.27

1858

6903

(3008898) HLA-B27 [Presence]

874

941

4.99

301.98

1.1

1.0

—

(3021601) Nitrite [Presence] in Urine by Test strip

8815

31999

1.82

299.40

4.0

3.7

0.00

estimate

1.08

1921

7171

(3013826) Glucose [Moles/volume] in Serum or Plasma

9768

36640

1.82

297.96

5.0

5.8

6.69

6.86

mmol/l

10.18

9292

33894

(3035350) Ketones [Presence] in Urine by Test strip

8902

32458

1.82

297.34

4.1

3.8

6.30

4.01

estimate

0.46

1949

7306

(3002030) Lymphocytes/Leukocytes in Blood

8340

29804

1.83

297.03

6.5

7.1

27.58

26.59

12.10

7889

28302

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

6462

21572

1.85

281.03

4.2

3.9

65.02

78.42

ng/l

0.36

4347

15965

(3037522) Nuclear Ab [Titer] in Serum

2607

6167

2.38

278.70

1.4

1.3

451.34

537.42

titre

1.43

508

1279

(3015736) pH of Urine

7323

25506

1.81

277.27

3.5

3.4

6.19

6.28

10.21

4220

13948

(3018095) Leukocytes [#/volume] in Urine

6722

22814

1.83

276.33

4.3

4.4

88.78

139.20

e6/l

3.16

4793

16073

(3020564) Creatinine [Moles/volume] in Serum or Plasma

15560

68831

2.19

274.13

23.0

19.4

80.42

82.48

umol/l

9.23

15382

67625

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

7784

27818

1.78

268.05

2.9

—

estimate

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

13918

59301

1.92

266.64

5.2

4.4

5.94

5.91

mmol/l

2.00

12785

54430

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

5354

17200

1.86

257.17

2.3

198.42

270.98

u/l

5.69

5075

16265

(40768804) Tissue Pathology biopsy report

6300

21319

1.81

256.60

2.2

2.1

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

5536

18098

1.84

250.48

2.8

72.07

64.16

u/l

0.23

5127

16876

(3002582) Erythrocytes [#/volume] in Urine

5966

19970

1.81

250.25

3.7

3.8

83.16

112.91

e6/l

0.70

4571

15419

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

7447

26687

1.75

248.06

2.3

2.0

95.23

93.17

pmol/l

2.93

4020

15054

(3044640) Blood type and Crossmatch panel - Blood

5696

18841

1.82

247.68

2.5

2.7

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

15384

68508

2.06

244.20

12.7

10.2

27.25

25.89

u/l

6.68

14999

66107

(36304419) Bacteria [Presence] in Urine

5026

16212

1.83

234.12

3.5

3.6

640.32

281.07

estimate

0.22

107

(3030467) Casts [#/volume] in Urine by Automated count

5226

17086

1.82

232.97

3.6

3.8

0.40

0.51

e6/l

2.56

3877

12772

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

8144

30550

1.69

222.44

6.6

9.2

1.21

mmol/l

3.85

6978

26258

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

14384

63238

1.85

219.57

5.6

4.8

2.65

2.66

mmol/l

0.59

13403

59028

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

7333

26830

1.69

218.28

6.0

8.4

1.21

mmol/l

6.81

6748

24896

(3032080) INR in Blood by Coagulation assay

7784

28966

1.68

217.37

13.9

22.7

1.25

1.41

inr

98.12

6501

24890

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

13460

58104

1.77

215.57

4.2

3.8

1.33

1.22

mmol/l

47.30

12413

53851

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

7245

26608

1.68

210.31

2.5

75.69

74.90

nmol/l

1.40

6542

24300

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

14160

62216

1.81

210.11

5.0

4.4

4.51

4.53

mmol/l

0.89

13281

58297

(3014051) Protein [Presence] in Urine by Test strip

5130

17133

1.76

208.63

3.1

0.00

0.08

7.39

607

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

14063

61763

1.79

206.58

4.9

4.3

1.39

1.43

mmol/l

27.37

13094

57630

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

4341

13819

1.82

206.37

2.4

2.6

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

5611

19410

1.72

200.21

3.0

3.8

2.35

2.34

mmol/l

3.15

5045

17660

(3007164) IgA [Mass/volume] in Serum or Plasma

3645

11238

1.85

189.40

1.5

2.37

2.44

g/l

1.07

2266

7113

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

4047

12919

1.80

187.99

1.4

1.3

1.66

2.01

u/ml

0.72

1107

3393

(3001122) Ferritin [Mass/volume] in Serum or Plasma

8116

31388

1.61

184.60

3.3

117.62

127.74

ug/l

2.46

7544

29355

(3000850) Epithelial cells [#/volume] in Urine

4221

13718

1.77

184.19

2.8

3.2

5.59

5.36

e6/l

0.44

3826

12502

(3024561) Albumin [Mass/volume] in Serum or Plasma

7322

27637

1.62

183.38

4.7

6.2

35.73

34.96

g/l

21.46

6836

25878

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

6602

24322

1.63

181.61

4.0

3.7

0.44

0.34

estimate

0.10

1604

5854

(3033658) Prothrombin time (PT) actual/Normal

4422

14866

1.71

169.25

4.3

4.8

88.81

83.70

30.50

4327

14552

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

5047

17727

1.65

163.09

3.3

3.7

1593.27

2254.34

ng/l

13.15

4264

15691

(3013512) EKG study

5357

19109

1.64

163.01

3.9

3.8

0.50

0.75

0.83

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

5849

21349

1.61

162.25

5.7

5.0

2.80

4.98

ug/l

4.08

5248

19105

(3007461) Platelets [#/volume] in Blood

15791

73374

1.87

159.26

27.5

22.5

249.84

246.40

e9/l

8.58

15528

71137

(3048689) Calprotectin [Mass/mass] in Stool

2447

6972

1.94

158.12

2.4

3.4

134.98

155.32

ug/g

1.46

1958

5673

(3024731) MCV [Entitic mean volume] in Red Blood Cells

15794

73456

1.87

157.15

27.4

22.4

91.10

90.53

43.04

15651

72297

(3010813) Leukocytes [#/volume] in Blood

15797

73477

1.87

157.07

27.6

22.5

6.96

6.81

e9/l

10.94

15479

70974

(3035941) MCH [Entitic mass]

15792

73450

1.87

156.95

27.4

22.4

30.34

30.16

31.87

15649

72291

(3026361) Erythrocytes [#/volume] in Blood

15794

73466

1.87

156.82

27.5

22.5

4.49

4.50

e12/l

0.32

15467

70990

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

15791

73458

1.86

156.48

27.9

23.0

40.93

40.94

0.00

15640

72211

(3041096) Erythrocytes [Presence] in Urine by Automated

5020

17774

1.64

155.84

3.5

3.4

0.26

0.21

estimate

0.10

1548

5487

(3000963) Hemoglobin [Mass/volume] in Blood

15794

73497

1.86

155.80

27.7

22.6

135.28

134.71

g/l

4.55

15652

72382

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

3632

11784

1.74

155.60

3.4

3.0

0.78

0.90

ug/l

5.37

2343

8026

(3021960) Folate [Moles/volume] in Serum or Plasma

4875

17271

1.63

149.82

1.8

1.7

19.62

19.25

nmol/l

0.94

4183

15091

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1302

2952

2.38

147.68

2.5

2.3

17.99

20.06

au/ml

0.43

144

293

(1002224) Polysomnography panel

924

1763

2.80

146.55

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

578

823

3.72

143.30

1.5

1.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3257

10527

1.73

139.51

3.2

3.3

1.05

1.18

e6/l

0.70

1631

5750

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1197

2688

2.39

138.31

1.3

48.46

62.46

au/ml

1.05

170

(3000475) Leukocytes [#/volume] in Synovial fluid

507

674

3.97

137.22

1.8

1.5

15584.19

14530.56

e6/l

0.16

356

483

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

4633

16520

1.60

136.30

4.5

4.2

22.09

22.56

1.07

2157

8453

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5693

21477

1.54

130.23

3.2

3.4

34.77

33.74

u/l

0.14

5337

20325

(3023368) Bacteria identified in Blood by Culture

4976

18271

1.56

127.77

4.5

4.7

—

(3007853) Bacteria identified in Skin by Aerobe culture

2242

6635

1.85

127.32

1.8

1.9

—

(3042936) Bacteria identified in Isolate by Culture

2623

8177

1.77

125.85

2.0

2.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

3077

10044

1.70

125.77

3.3

3.4

2.34

2.50

e6/l

0.36

1442

5238

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

6075

23420

1.51

124.37

1.9

1.41

1.30

mmol/l

13.95

5124

20135

(3011397) Hemoglobin [Presence] in Urine by Test strip

4047

14229

1.60

124.13

3.8

3.6

0.04

0.17

1.43

188

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1889

5349

1.92

122.14

2.6

2.8

35.31

40.16

u/l

0.90

1571

4589

(40758558) Short blood count panel - Blood

4903

18116

1.55

121.19

6.0

7.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

3241

10833

1.66

120.83

2.7

3.2

2.44

2.45

mmol/l

1.39

2822

9632

(3009508) Creatinine [Moles/volume] in Urine

5576

21208

1.52

120.71

3.5

3.9

7.92

7.55

mmol/l

6.21

4647

18356

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

4756

17620

1.54

114.96

2.4

2.82

2.89

mg/l

0.88

4077

15217

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

2613

8407

1.71

111.14

2.5

2.1

—

(3021589) Normoblasts [#/volume] in Blood

7117

28813

1.46

110.66

11.7

12.1

0.00

e9/l

1.53

5709

23645

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

2806

9218

1.68

110.56

2.7

2.2

—

(3026008) Bacteria identified in Urine by Culture

5130

19473

1.50

109.75

3.3

3.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3412

11816

1.61

109.36

4.1

3.9

222.65

679.17

ng/l

11.30

2626

9578

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1779

5119

1.88

109.02

2.5

2.0

12.79

12.50

nmol/l

0.61

1590

4626

(3026782) Osmolality of Urine

3652

12895

1.58

107.79

3.0

3.4

539.43

536.45

mosm/kgh2o

0.32

3201

11410

(3013139) Helicobacter pylori Ag [Presence] in Stool

1238

3140

2.11

107.22

1.3

1.2

—

(3017732) Neutrophils [#/volume] in Blood

2197

6811

1.76

105.95

2.9

3.9

4.69

4.66

e9/l

0.05

1901

5931

(3001019) Free T4 and TSH panel - Serum or Plasma

878

1939

2.41

104.47

1.6

1.5

—

(3002256) Pathology report gross observation

2218

6934

1.74

103.79

1.4

1.3

—

(3022145) Colonoscopy Study observation

1937

5829

1.80

102.89

1.4

1.5

—

(3029937) Albumin [Presence] in Urine by Test strip

4703

17736

1.50

102.35

4.2

3.8

0.00

estimate

0.23

1785

6188

(3026470) Cobalt [Mass/volume] in Blood

137

15.50

101.27

2.1

1.7

4.26

1.78

ug/l

2.10

124

(3018418) pH of Serum or Plasma

4870

18535

1.49

101.16

3.9

5.6

7.40

1.26

3452

13506

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1745

5134

1.84

99.41

2.1

2.3

377.72

406.21

nmol/l

5.04

1609

4794

(3025577) Chromium [Mass/volume] in Blood

134

15.49

99.05

2.1

1.7

2.35

1.58

ug/l

1.06

110

(3000494) Fungus identified in Specimen by Culture

2071

6429

1.75

98.95

1.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

455

716

3.34

98.02

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

455

716

3.34

98.02

1.1

—

(3045414) Leukocytes [Presence] in Urine

1698

4982

1.84

97.47

2.1

0.01

0.03

estimate

1.01

333

1158

(3019225) pH of Specimen

1644

4793

1.85

96.20

4.1

5.2

7.36

0.10

1180

3485

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2144

6775

1.72

96.11

2.8

3.0

7.79

10.77

umol/l

7.59

1866

5961

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1255

3345

2.01

95.16

1.4

1.5

—

(3012516) Albumin [Mass/volume] in Urine

4912

19014

1.46

91.94

3.5

4.0

54.13

67.59

mg/l

2.64

3241

13077

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2346

7707

1.66

90.83

1.9

1.7

1.44

1.45

0.13

2040

6827

(3020682) Albumin/Creatinine [Ratio] in Urine

5048

19689

1.45

90.55

4.2

4.8

9.76

12.34

mg/mmol

2.76

3206

13343

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1899

5894

1.74

90.27

4.8

4.6

31.53

32.86

4.94

1309

3990

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

12339

56279

1.42

90.14

21.7

19.5

13.62

13.61

0.38

12172

55288

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

588

1141

2.72

89.99

1.2

1.3

8.97

38.48

u/ml

3.15

(3005322) IgE [Units/volume] in Serum or Plasma

1184

3174

1.99

88.18

1.3

196.82

337.73

u/ml

3.67

1098

2930

(36660697) Celiac disease serology panel - Serum

1484

4313

1.85

87.31

1.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

762

1711

2.36

87.30

1.6

2.1

6.97

9.34

iu/ml

1.14

162

391

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

554

1067

2.74

85.92

1.3

5.59

9.61

u/ml

0.83

151

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1055

2735

2.05

85.89

1.1

1.0

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

756

1710

2.34

85.22

1.6

1.7

14.34

20.30

u/ml

1.62

176

452

(3006571) Granulocytes/Leukocytes in Synovial fluid

273

326

4.38

83.90

1.7

1.5

58.70

62.26

0.52

172

217

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

552

1075

2.71

83.90

1.3

3.13

9.85

u/ml

0.67

(3015171) Extractable nuclear Ab [Units/volume] in Serum

698

1546

2.39

82.30

1.3

1.2

0.60

1.30

u/ml

0.65

107

(3025941) Bacteria identified in Stool by Culture

1088

2907

1.99

81.61

1.3

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

12411

57068

1.39

81.10

22.3

19.3

332.58

332.45

g/l

0.73

12335

56547

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3074

11061

1.53

80.45

2.0

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

931

2378

2.08

78.63

1.7

1.6

0.28

mg/l

0.16

410

989

(3019309) Folate [Moles/volume] in Red Blood Cells

3039

11072

1.50

74.37

1.8

1123.23

1154.46

nmol/l

0.95

2257

8442

(3024891) Influenza virus A+B Ag [Presence] in Specimen

614

1352

2.39

73.24

1.2

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

720

1753

2.17

68.40

2.1

1.6

38.75

45.20

nmol/l

9.26

703

1723

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

459

912

2.64

67.19

1.2

1.3

2.66

8.23

u/ml

0.80

(3022621) pH of Urine by Test strip

1481

4669

1.70

65.57

2.8

2.7

6.07

6.15

1.97

970

3413

(3020961) Endomysium IgA Ab [Titer] in Serum

894

2408

1.97

65.29

1.1

189.20

205.68

titre

0.09

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

546

1212

2.37

63.99

2.1

1.6

212.03

200.93

pmol/l

1.17

521

1150

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

434

863

2.64

63.44

1.2

1.3

48.36

44.32

u/ml

0.13

(3019150) Specific gravity of Urine by Refractometry

3790

14840

1.40

62.16

4.1

3.6

1.78

1.12

kg/l

0.64

2642

9772

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

550

1260

2.29

60.15

1.3

—

(3045424) Erythrocytes [Presence] in Urine

888

2493

1.88

57.42

2.1

0.97

0.09

estimate

0.44

258

829

(3003327) Ova and parasites identified in Stool by Light microscopy

715

1890

1.99

54.90

1.7

—

(40761536) Microorganisms panel - Urine sediment

1525

5077

1.60

54.33

4.1

4.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1352

4377

1.64

53.80

2.5

3.0

10.35

11.04

g/l

6.77

1231

4064

(3023323) Follitropin [Units/volume] in Serum or Plasma

876

2505

1.85

53.51

1.4

18.59

22.79

iu/l

3.41

740

2083

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

3312

12979

1.39

52.84

1.8

1.7

19912738.28

28298990.61

pmol/l

0.45

2737

10785

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

716

1921

1.96

52.75

3.6

4.8

24.64

24.51

mmol/l

0.45

650

1739

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

717

1929

1.96

52.41

2.3

1.8

—

(3004616) Nuclear Ab [Presence] in Serum

262

434

3.15

52.34

1.3

1.2

—

(40768443) Skin Pathology biopsy report

800

2237

1.89

52.29

1.3

1.2

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1284

4140

1.65

51.84

3.6

4.3

5.13

kpa

0.02

1221

3936

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1770

6170

1.53

51.64

3.7

3.8

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

286

506

2.95

51.43

1.1

1.2

3.10

29.83

u/ml

1.38

(3004588) Protein electrophoresis panel - Serum or Plasma

1219

3896

1.66

50.86

2.1

2.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

473

1095

2.27

50.52

1.2

1.1

4.48

3.83

0.57

(3009343) pH of Capillary blood

1254

4052

1.64

50.16

3.6

4.2

7.41

0.31

1046

3456

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

780

2195

1.87

50.00

2.1

2.0

—

(3022313) Gas panel - Capillary blood

879

2579

1.80

49.44

3.8

4.5

—

(4094501) Cardiovascular stress test using bicycle ergometer

443

1006

2.31

49.41

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

560

1421

2.07

47.90

1.5

1.4

274.98

259.12

ug/g

0.84

324

853

(21494755) Public health laboratory ask at order entry panel

1600

5543

1.54

47.81

1.3

1.2

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

183

252

3.78

47.51

1.6

1.4

32.10

28.23

0.51

105

172

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

722

2015

1.89

47.43

2.0

1.8

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1189

3847

1.64

47.24

1.7

—

(3023511) Choriogonadotropin [Units/volume] in Urine

544

1381

2.07

46.48

1.5

1.3

—

(3022948) Iron [Moles/volume] in Serum or Plasma

3045

11993

1.37

46.38

2.4

3.3

13.05

12.55

umol/l

2.77

2827

11178

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

867

2591

1.77

45.86

2.5

2.3

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1492

5144

1.54

45.46

2.4

2.6

66.38

65.59

g/l

3.29

1366

4726

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

332

691

2.51

44.50

1.1

26.15

22.24

au/ml

0.19

156

(3014111) Lactate [Moles/volume] in Serum or Plasma

1709

6112

1.49

43.86

6.4

9.1

1.35

1.40

mmol/l

1.07

1668

5971

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

760

2219

1.80

43.38

1.8

2.0

38.07

38.44

u/l

0.19

669

1932

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2767

10861

1.37

42.64

2.8

4.1

0.82

mmol/l

0.52

2579

10251

(42529406) Shigella sp [Presence] in Stool by Culture

530

1387

2.00

41.80

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

528

1380

2.01

41.78

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

171

252

3.53

40.62

1.4

108260.90

91974.11

e6/l

0.12

125

168

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1103

3637

1.60

40.49

3.4

4.1

1.47

1.76

mmol/l

1.47

780

2618

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

631

1776

1.87

40.39

1.5

1.6

11.77

1.46

iu/ml

0.43

104

399

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

521

1377

1.98

40.00

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1394

4875

1.52

39.61

2.4

2.3

6.72

9.89

ug/l

5.37

1166

4265

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2843

11327

1.35

39.57

2.3

3.3

2.32

2.27

g/l

4.46

2600

10514

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2200

8411

1.40

39.40

1.8

1.9

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1063

3499

1.61

39.28

1.8

1.9

1.23

1.36

g/l

1.39

975

3215

(3011288) Drugs identified in Urine by Screen method Nominal

809

2488

1.71

38.69

3.6

2.5

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

207

359

3.00

38.58

1.2

71.43

19.79

u/ml

—

(3016879) Cocaine [Presence] in Urine

1026

3380

1.60

37.76

2.5

2.0

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

400

979

2.14

37.52

1.7

1.5

—

(3034891) Synovial lining cells/cells in Synovial fluid

113

128

4.58

37.04

1.4

4.81

2.04

0.97

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

675

2000

1.77

36.69

2.3

2.5

0.89

0.96

g/l

0.16

590

1706

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

942

3071

1.62

36.14

2.9

2.4

5566.42

8337.28

u/l

1.65

352

1345

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

721

2191

1.73

35.96

2.2

2.4

2.95

g/l

0.00

656

1986

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1615

5937

1.45

35.72

2.5

2.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

256

523

2.55

35.68

2.2

2.0

21.60

30.99

mg/l

1.87

102

193

(3028707) Methadone [Presence] in Urine by Screen method

526

1456

1.89

35.41

3.3

2.8

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2621

10485

1.34

35.10

2.4

3.5

22.53

22.27

0.42

2423

9768

(3027008) Opiates [Presence] in Urine

1076

3662

1.55

34.45

2.4

1.9

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

763

2385

1.68

34.39

2.1

2.3

4.20

4.15

g/l

1.02

700

2183

(3028300) Cannabinoids [Presence] in Urine

1077

3670

1.55

34.29

2.4

2.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1570

5784

1.44

34.27

7.5

7.6

—

(3000764) Benzodiazepines [Presence] in Urine

1069

3640

1.55

34.14

2.4

2.0

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

763

2390

1.68

34.12

2.1

2.3

7.44

7.28

g/l

1.64

696

2185

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

761

2384

1.68

34.02

2.1

2.3

3.77

3.73

g/l

0.25

697

2183

(3027944) Amphetamines [Presence] in Urine

1061

3613

1.55

33.87

2.3

2.0

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

201

373

2.80

33.49

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

657

1985

1.74

33.43

1.4

8.27

9.05

u/l

0.87

541

1580

(3039443) Prostate specific Ag panel - Serum or Plasma

307

706

2.27

33.40

1.6

1.5

—

(3036670) Protein [Mass/volume] in Synovial fluid

5.67

33.21

1.2

39.31

41.05

g/l

0.32

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2065

8025

1.37

33.15

1.9

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

189

344

2.86

32.58

1.2

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

532

1521

1.83

32.47

2.3

2.4

0.00

g/l

-0.00

502

1418

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

183

328

2.90

32.38

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

183

329

2.89

32.21

1.2

—

(3027945) Reticulocytes/Erythrocytes in Blood

2084

8147

1.36

32.18

2.4

2.9

1.78

1.77

0.04

1830

7272

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1779

6785

1.39

31.90

1.8

—

8.25

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

556

1621

1.80

31.88

2.3

0.00

g/l

0.11

503

1420

(3002179) Metamyelocytes/Leukocytes in Blood

1501

5556

1.43

31.85

4.1

4.9

0.61

0.79

1.68

447

1771

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2159

8502

1.35

31.80

1.6

1.5

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

580

1717

1.77

31.63

2.2

2.3

0.06

0.03

g/l

0.61

536

1530

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

177

318

2.89

31.21

1.2

—

(3003694) ABO and Rh group [Type] in Blood

4730

20695

1.24

31.15

1.5

1.6

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

183

336

2.83

31.10

1.2

—

(3025159) Blasts/Leukocytes in Blood

1510

5626

1.42

30.88

4.4

5.3

0.11

0.23

1.04

375

1574

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

450

1240

1.90

30.74

1.1

2.23

3.07

u/ml

0.75

232

714

(3003888) Timothy IgE Ab [Units/volume] in Serum

405

1076

1.97

30.71

1.1

7.09

6.68

u/ml

0.14

213

610

(3038177) Helicobacter pylori Ab [Presence] in Serum

331

818

2.11

30.39

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1348

4935

1.44

30.29

2.4

2.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

667

2082

1.68

30.21

2.2

2.3

10.18

10.67

g/l

1.79

599

1858

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1582

5975

1.40

29.94

2.2

2.4

0.21

0.20

g/l

5.26

1457

5534

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1021

3542

1.52

29.92

3.4

3.7

4.52

4.49

pmol/l

0.50

919

3217

(3047007) Chlamydophila sp Ab [Presence] in Serum

257

575

2.33

29.78

1.2

—

(3021440) Promyelocytes/Leukocytes in Blood

1507

5651

1.41

29.70

4.3

5.1

0.10

0.08

0.35

402

1663

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

838

2787

1.58

29.58

1.1

1.01

7.04

u/ml

—

(3038026) Centromere Ab [Units/volume] in Serum

150

252

3.09

29.53

1.2

94.28

54.34

u/ml

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1330

4880

1.44

29.51

1.6

1.8

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

880

2969

1.56

29.21

1.3

1.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1146

4094

1.48

29.17

1.2

128.51

145.33

u/ml

0.44

384

1532

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

174

323

2.80

29.04

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

385

1028

1.96

28.82

1.1

0.95

0.94

u/ml

0.01

162

500

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1387

5153

1.42

28.75

2.5

2.9

0.50

0.47

e6/l

0.13

1322

4995

(3018333) Ribosomal P Ab [Presence] in Serum

169

313

2.81

28.33

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

563

1723

1.71

27.41

3.1

3.7

1.38

2.26

index

3.10

308

929

(3014133) Dog dander IgE Ab [Units/volume] in Serum

329

845

2.03

27.40

1.1

2.90

4.46

u/ml

1.33

162

467

(3017143) Hepatitis C virus Ab [Presence] in Serum

2213

8929

1.32

27.39

1.7

1.9

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

286

696

2.14

27.32

1.1

0.10

0.29

u/ml

1.85

222

(3017181) Myelocytes/Leukocytes in Blood

1554

5942

1.38

27.26

4.3

5.0

0.79

0.89

0.69

449

1938

(3010726) Horse dander IgE Ab [Units/volume] in Serum

379

1027

1.93

27.23

1.1

2.15

2.08

u/ml

0.04

185

570

(3023430) Cat dander IgE Ab [Units/volume] in Serum

314

801

2.04

26.64

1.1

4.82

5.56

u/ml

0.26

132

396

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1198

4410

1.43

26.05

7.2

10.0

24.83

24.44

mmol/l

2.66

1191

4367

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

273

666

2.14

25.95

1.1

2.20

2.94

eliau/ml

0.65

121

282

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

240

555

2.25

25.90

1.2

1.1

2.70

2.67

0.01

(3021387) Prolactin [Units/volume] in Serum or Plasma

813

2769

1.54

25.88

1.6

1.8

299.19

355.46

mu/l

2.53

732

2471

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

253

601

2.19

25.65

1.3

1.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

498

1501

1.73

25.60

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

249

589

2.20

25.50

1.3

1.5

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

473

1409

1.75

25.31

1.9

2.1

11.74

12.89

mg/l

0.99

437

1323

(4024509) Urine culture

760

2563

1.56

25.27

2.0

1.9

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1102

4017

1.44

25.24

8.3

11.1

24.09

24.07

mmol/l

0.05

1074

3895

(3049717) Cytology report of Urine Cyto stain

700

2317

1.58

25.20

2.7

2.9

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2538

10540

1.28

25.18

2.0

2.5

29.93

30.12

0.77

2469

10253

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

669

2193

1.60

25.08

1.2

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1747

6894

1.34

25.04

1.9

1.6

3.59

3.42

ratio

5.18

1345

4972

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

245

585

2.18

24.56

1.3

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

236

557

2.21

24.32

1.3

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

236

557

2.21

24.32

1.3

1.5

—

(3023520) Reticulocytes [#/volume] in Blood

1591

6217

1.35

24.28

2.5

2.9

69.02

67.54

e9/l

0.81

1110

4569

(3009445) Proteinase 3 Ab [Units/volume] in Serum

760

2587

1.54

24.25

1.4

1.7

20.26

13.22

iu/ml

0.25

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2015

8164

1.31

24.00

3.9

4.9

235.85

251.83

u/l

2.82

1899

7835

(3039162) Centromere protein B Ab [Units/volume] in Serum

227

531

2.22

23.90

1.1

1.3

93.38

50.45

u/ml

—

(3035320) C reactive protein [Mass/volume] in Body fluid

181

382

2.46

23.82

2.7

2.5

27.28

32.74

mg/l

0.85

130

283

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

449

1342

1.75

23.78

1.3

530.46

550.73

mg/l

0.26

425

1280

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

127

221

2.98

23.73

1.1

1.0

6.57

8.38

iu/ml

0.41

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

526

1648

1.67

23.55

1.5

1.9

1.18

1.15

g/l

1.66

499

1576

(3025468) Yersinia sp identified in Specimen by Organism specific culture

232

556

2.17

23.08

1.3

1.5

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

473

1450

1.70

22.94

1.1

2.31

8.09

eliau/ml

3.18

160

(3024980) IgG subclass 4 [Mass/volume] in Serum

334

921

1.89

22.87

1.5

1.7

0.70

0.85

g/l

1.84

261

723

(3048929) Epstein Barr virus Ab [Presence] in Serum

708

2435

1.52

21.58

1.2

1.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

299

815

1.91

21.22

1.8

1.5

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

11.83

21.18

1.8

2.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

508

1626

1.63

20.99

1.5

1.9

0.23

g/l

0.10

483

1550

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

541

1764

1.60

20.77

1.3

1.6

5.36

8.66

iu/ml

0.91

(3000991) Gas panel - Venous blood

1535

6109

1.33

20.62

7.5

11.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

104

178

3.03

20.04

1.3

1.2

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

164

3.10

19.58

1.3

1.2

8.30

9.18

mm/h

0.33

164

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

393

1200

1.71

19.40

1.2

1.3

3.71

3.91

mmol/l

2.45

370

1134

(3010838) Calcium [Moles/time] in 24 hour Urine

297

835

1.85

19.26

2.0

1.9

4.80

4.64

mmol/24h

0.34

265

727

(3024263) Appearance of Synovial fluid

139

3.28

19.19

2.6

1.6

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

1196

4645

1.35

18.87

2.5

3.3

68.31

61.33

ml/min/173m2

5.86

489

2045

(46235355) HIV 1 and 2 tests - Meaningful Use set

3745

16695

1.20

18.77

2.2

—

(3003129) Base excess in Capillary blood by calculation

241

643

1.95

18.26

2.6

2.4

0.70

0.00

mmol/l

1.72

231

593

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

127

259

2.54

18.02

1.1

17.69

16.71

u/ml

0.11

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

165

385

2.23

17.61

1.8

2.3

19.64

19.26

nmol/l

0.17

155

371

(3014007) Fractional oxyhemoglobin in Arterial blood

1086

4205

1.36

17.47

8.6

11.8

93.79

93.77

0.03

1079

4190

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

967

3675

1.38

17.47

1.5

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1918

8030

1.26

17.39

6.8

8.7

12.06

12.32

kpa

1.23

1841

7689

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1083

4196

1.35

17.35

3.1

5.7

24.23

23.90

mmol/l

2.67

1065

4116

(3009015) Lactate [Moles/volume] in Synovial fluid

9.13

17.33

1.2

1.1

6.31

6.27

mmol/l

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1917

8032

1.26

17.26

6.8

8.7

5.10

5.02

kpa

2.52

1839

7690

(3037121) Protein [Mass/volume] in Urine

622

2186

1.49

17.16

3.0

4.0

506.91

516.89

mg/l

0.02

274

1212

(3016018) Differential panel - Cerebral spinal fluid

216

568

1.98

17.07

1.2

1.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

260

730

1.85

16.99

1.3

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

418

1348

1.62

16.85

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

418

1348

1.62

16.85

1.4

1.3

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1089

4244

1.35

16.79

8.5

11.5

1.31

1.32

0.12

1081

4212

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

385

1217

1.65

16.78

1.3

1.5

1095.69

1160.16

e6/l

0.04

291

983

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

696

2513

1.45

16.77

2.1

2.7

767.36

669.99

ug/l

0.12

656

2389

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1063

4140

1.35

16.46

8.7

11.8

0.61

0.64

1.43

1052

4115

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

122

256

2.47

16.41

1.1

6.85

8.33

nmol/l

0.11

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

242

672

1.87

16.38

1.3

0.18

0.25

nmol/l

0.62

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

595

2096

1.48

16.25

1.8

1.7

4.08

4.53

mg/l

0.37

458

1328

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

380

1208

1.64

16.23

1.3

1.5

20.61

49.85

e6/l

1.61

270

915

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

180

2.77

15.97

1.1

1.2

—

(3003396) Base excess in Arterial blood by calculation

1893

7989

1.25

15.96

6.8

8.6

0.69

0.94

mmol/l

1.70

1543

6432

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

102

198

2.67

15.95

1.2

—

(3019977) pH of Arterial blood

1901

8036

1.25

15.79

6.9

8.7

7.41

7.42

0.92

1000

4533

(3042517) Benzodiazepines panel - Urine

4.26

15.68

2.8

2.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

110

226

2.52

15.46

3.7

2.3

201.52

139.79

umol/l

0.88

100

(3015235) Bicarbonate [Moles/volume] in Capillary blood

674

2457

1.43

15.46

3.0

3.3

24.37

24.48

mmol/l

0.29

666

2407

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

236

663

1.85

15.45

1.3

0.60

1.63

nmol/l

0.84

224

636

(3006442) Creatine [Moles/volume] in Serum or Plasma

140

323

2.25

15.40

1.5

1.6

83.32

95.95

umol/l

2.40

140

323

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

349

1101

1.65

15.37

1.1

1.3

274.55

318.90

titre

0.13

(3024139) IgG subclass 3 [Mass/volume] in Serum

205

551

1.93

15.30

1.5

1.3

0.36

0.44

g/l

2.15

145

387

(3028192) IgG subclass 2 [Mass/volume] in Serum

205

552

1.93

15.22

1.5

1.3

2.84

3.11

g/l

1.31

145

391

(3027135) IgG subclass 1 [Mass/volume] in Serum

205

552

1.93

15.22

1.5

1.3

6.19

7.32

g/l

3.14

146

391

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

184

479

1.99

15.02

2.1

2.3

—

(4062490) Immunoglobulin typing, IgG

201

542

1.93

14.88

1.5

1.3

—

(3016502) Oxygen saturation in Arterial blood

1690

7099

1.25

14.80

7.0

9.2

95.35

95.27

0.17

1642

6838

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

522

1828

1.49

14.71

1.7

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

376

1223

1.60

14.70

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

379

2991

0.65

14.63

1.5

1.8

—

(44813793) Dust mix specific IgE antibody measurement

139

328

2.20

14.55

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

245

711

1.79

14.51

1.7

1.9

366.40

461.28

mu/l

2.16

203

592

(3026389) Candida sp identified in Specimen by Organism specific culture

247

719

1.79

14.48

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

3.67

14.39

1.0

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

3.67

14.39

1.0

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

3.67

14.39

1.0

1.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

635

2333

1.42

13.99

3.0

3.5

47.41

93.41

u/ml

2.79

617

2260

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

147

2.82

13.85

1.1

1.2

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1304

5352

1.28

13.83

1.7

1.5

3.43

3.45

mmol/l

0.17

919

3409

(3023410) Appearance of Cerebral spinal fluid

188

510

1.91

13.72

1.4

1.6

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

185

500

1.92

13.65

1.0

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

143

2.83

13.57

1.8

2.3

1.22

0.93

ug/l

0.49

137

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1315

5421

1.27

13.46

2.9

3.4

227.12

301.13

ng/l

5.03

1173

4998

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1264

5189

1.28

13.38

3.5

4.9

1.22

mmol/l

0.11

1075

4524

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2197

9591

1.21

13.30

4.9

9.3

1.04

1.06

mmol/l

2.51

2039

8969

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

138

339

2.11

13.16

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

139

344

2.10

13.02

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

143

358

2.07

13.01

1.2

—

(40768446) Kidney Pathology biopsy report

555

0.26

12.99

1.8

2.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

314

1010

1.62

12.90

1.6

0.43

0.40

nmol/l

0.23

256

831

(3002619) Bacteria identified in Specimen by Culture

116

2.99

12.84

1.1

1.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

598

2209

1.41

12.81

3.0

3.2

32.89

53.07

mg/l

5.85

506

1846

(3017354) Segmented neutrophils/Leukocytes in Blood

220

646

1.77

12.60

3.8

3.9

55.71

58.08

0.78

191

540

(3034860) Kappa light chains.free [Mass/volume] in Serum

597

2212

1.41

12.58

3.0

3.2

49.80

62.75

mg/l

2.38

507

1847

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

3.43

12.48

1.2

1.3

1.19

1.16

mmol/l

1.39

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

216

2.38

12.41

1.4

1.5

6.94

7.28

u/l

0.07

180

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1203

4958

1.27

12.34

3.4

6.2

86.71

116.27

ng/l

19.07

1027

4318

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

208

605

1.79

12.31

3.5

4.4

—

(3016244) Insulin [Units/volume] in Serum or Plasma

122

294

2.15

12.23

3.4

2.6

24.62

19.61

mu/l

1.15

115

270

(4146454) Self-monitoring of blood glucose

192

546

1.83

12.21

2.5

2.7

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

4.89

12.17

1.0

5.00

7.60

u/ml

0.48

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

572

2119

1.41

12.08

1.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1484

6283

1.24

12.07

3.7

4.5

20.52

25.11

ug/l

0.28

1172

5196

(3015076) Soybean IgE Ab [Units/volume] in Serum

117

279

2.17

12.03

1.1

1.0

0.63

0.42

u/ml

0.44

(3036071) Salmonella sp Ab [Titer] in Serum

130

2.79

11.96

1.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

688

0.36

11.93

16.5

30.2

124.69

101.32

ug/l

1.71

580

(3024928) Oxygen saturation in Venous blood

500

1816

1.43

11.79

2.4

4.2

60.69

63.73

2.27

479

1717

(3020911) Cortisol [Moles/time] in 24 hour Urine

149

2.61

11.37

1.3

1.5

159.02

427.30

nmol/24h

0.52

149

(3007566) Smooth muscle Ab [Titer] in Serum

468

1691

1.44

11.36

1.2

1.3

84.17

94.00

titre

0.24

165

(4035726) Immunohistochemistry procedure

1194

4969

1.26

11.30

1.4

1.5

—

(3034770) Mitochondria Ab [Titer] in Serum

457

1646

1.45

11.28

1.2

1.3

986.00

906.60

titre

—

(3035933) Granulocytes/Leukocytes in Blood

406

1429

1.48

11.27

3.3

3.9

57.81

59.18

1.39

406

1429

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

231

712

1.69

11.24

1.3

16.53

22.15

u/l

2.33

191

597

(3035637) Corticotropin [Mass/volume] in Plasma

218

662

1.71

11.19

1.5

1.6

27.74

34.95

ng/l

0.72

218

662

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

577

2171

1.39

11.16

1.1

0.67

0.60

ratio

1.61

212

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1537

6602

1.22

10.89

7.5

9.8

122.00

119.55

g/l

4.49

1511

6443

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

178

2.42

10.85

1.1

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

440

1587

1.44

10.80

1.5

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

198

592

1.74

10.75

1.3

0.18

0.20

nmol/l

1.32

153

487

(3010421) pH of Blood

579

2195

1.37

10.72

4.1

4.5

7.41

0.66

572

2156

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

141

379

1.93

10.68

1.3

1.4

2.48

1.92

u/ml

0.19

224

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

154

427

1.87

10.65

1.4

1.2

231.31

186.73

pmol/l

0.34

154

427

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

148

406

1.89

10.57

1.1

271.19

271.21

mg/l

0.00

131

356

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

152

2.52

10.56

2.1

2.6

8.91

9.34

mg/l

0.23

129

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

569

0.34

10.44

1.7

2.9

149.69

154.38

nmol/l

0.10

498

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

439

1594

1.43

10.42

1.9

2.0

3.20

5.22

iu/l

0.83

168

685

(37208534) Antinuclear antibody arbitrary concentration in serum

150

2.52

10.41

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

143

390

1.90

10.40

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

5.62

10.23

1.4

1.6

310.88

354.65

umol/24h

0.41

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

153

430

1.85

10.18

1.2

1.1

38.71

50.73

mg/l

2.20

127

365

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

534

2017

1.38

10.13

2.9

3.1

3.91

3.48

ratio

0.15

298

1160

(3024354) Oxygen [Partial pressure] in Venous blood

1455

6261

1.22

10.12

2.8

3.9

4.55

4.64

kpa

0.62

1399

6050

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

103

2.81

9.81

1.7

1.8

151.60

112.03

au/ml

0.23

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

225

2.16

9.68

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

113

293

2.00

9.51

1.1

1.09

1.16

u/l

0.33

100

(3020874) Milk IgE Ab [Units/volume] in Serum

123

331

1.93

9.35

1.1

1.0

0.84

1.50

u/ml

0.38

105

(3014599) Egg white IgE Ab [Units/volume] in Serum

118

313

1.95

9.34

1.1

1.0

0.37

2.76

u/ml

1.47

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

227

2.12

9.16

1.6

1.8

1.48

3.58

u/ml

0.74

(40768800) Prostate Pathology biopsy report

365

1318

1.44

8.99

1.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

315

2336

0.69

8.97

1.4

1.6

57.80

64.34

ug/l

2.05

315

2336

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

195

2.20

8.97

1.3

1.2

—

(3012544) pH of Venous blood

1731

7668

1.18

8.81

3.3

5.1

7.38

7.37

0.52

943

4827

(3042733) HLA Ab [Presence] in Serum

516

0.37

8.80

3.4

5.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

576

2258

1.33

8.67

2.6

2.8

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

3004

13898

1.14

8.58

1.7

1.9

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

316

1123

1.46

8.48

1.3

28.68

38.63

u/l

0.85

272

972

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

2.72

8.48

1.5

1.9

0.40

0.46

ug/l

0.38

(3032773) Endomysium IgG Ab [Titer] in Serum

170

523

1.69

8.46

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

4.96

8.41

1.3

1.0

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1713

7612

1.18

8.39

3.2

5.1

5.85

5.79

kpa

1.31

1654

7387

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

231

770

1.56

8.37

1.1

1.51

1.55

g/l

0.69

208

716

(3032057) Clostridioides difficile [Presence] in Stool

2.79

8.35

2.1

1.9

—

(3002032) Base excess in Venous blood by calculation

1669

7406

1.18

8.32

3.2

5.1

1.75

1.59

mmol/l

0.86

1459

6357

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

145

430

1.75

8.22

1.0

1.1

292.09

292.58

mg/l

0.02

128

393

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

903

3782

1.25

8.14

2.4

3.7

1.33

1.20

1.93

895

3761

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

892

3731

1.25

8.13

2.4

3.7

0.59

0.64

5.07

885

3717

(3013290) Carbon dioxide [Partial pressure] in Blood

403

1510

1.39

8.12

4.8

4.9

5.02

4.99

kpa

0.23

394

1468

(3012501) Base excess in Blood by calculation

403

1510

1.39

8.12

4.8

4.9

2.62

2.68

mmol/l

0.16

253

996

(3020491) Glucose [Moles/volume] in Blood

144

428

1.74

8.11

1.7

7.01

6.80

mmol/l

0.27

104

312

(3007463) Buprenorphine [Presence] in Urine

5.44

7.99

4.7

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

175

2.19

7.93

1.0

16.30

13.76

u/ml

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

210

695

1.57

7.88

1.0

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

583

3859

0.77

7.87

1.4

—

(3027315) Oxygen [Partial pressure] in Blood

403

1520

1.38

7.82

4.8

4.9

8.57

8.59

kpa

0.10

394

1477

(3011985) Renin [Units/volume] in Plasma

234

796

1.53

7.79

1.5

1.6

112.88

48.45

mu/l

1.25

205

716

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

141

422

1.73

7.77

1.6

24.17

28.67

u/ml

0.48

(3020191) Ethanol [Moles/volume] in Serum or Plasma

172

545

1.64

7.71

1.8

1.4

1.44

1.05

promille

2.29

132

435

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

315

1145

1.43

7.56

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

680

2781

1.27

7.52

1.4

1.5

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

3.38

7.52

1.0

1.1

71.81

91.65

ug/l

1.51

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

151

466

1.68

7.48

1.1

1.3

107.32

102.78

pmol/l

0.50

151

466

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

261

917

1.48

7.47

1.2

1.82

1.45

0.17

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.92

7.38

1.2

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

184

602

1.59

7.28

2.5

3.4

36.23

6.78

nmol/l

0.48

178

580

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

2.99

7.26

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

141

431

1.70

7.25

1.2

1.3

2.03

2.18

mmol/l

0.70

132

398

(3002079) Sodium [Moles/time] in 24 hour Urine

264

1.90

7.25

1.6

1.2

157.41

155.77

mmol/24h

0.06

264

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

207

2.03

7.20

2.3

2.9

116.53

525.68

ug/l

0.64

190

(4211845) Urine protein measurement

233

1.96

7.12

3.6

2.1

—

(3044927) Protein electrophoresis panel - Urine

172

559

1.60

7.01

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

147

2.22

7.01

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

273

1.86

6.86

1.4

1.6

5.54

12.07

ug/l

1.32

252

(3005011) Chlamydia sp Ab [Titer] in Serum

3.30

6.85

1.7

1.8

—

(40767503) Oxygen content in Capillary blood by calculation

395

1520

1.35

6.82

2.6

3.1

16.50

16.24

0.86

390

1487

(3045683) HLA typing for celiac disease panel - Blood or Tissue

263

1.87

6.78

1.0

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

119

354

1.74

6.76

1.4

1.3

90.00

599.43

titre

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

144

452

1.65

6.75

1.2

1.50

13.25

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

2.65

6.74

1.5

1.3

28.39

38.57

0.86

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

102

290

1.82

6.72

2.7

2.3

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

213

735

1.50

6.70

1.3

1.4

321.73

364.43

pmol/l

0.43

181

624

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

171

563

1.57

6.64

1.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

844

3594

1.22

6.58

1.8

2.0

1.47

1.44

g/l

0.40

720

3083

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

274

999

1.42

6.54

1.5

1.4

188.93

128.89

pmol/l

0.65

267

963

(3020779) Urea [Moles/volume] in Serum or Plasma

1593

7180

1.16

6.54

5.3

11.3

10.44

11.21

mmol/l

3.38

1519

6873

(4015189) Microbial culture of sputum

2.46

6.53

2.5

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

132

2.24

6.48

1.3

1.2

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

107

313

1.77

6.45

1.6

18.66

21.00

umol/l

0.38

291

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

256

1851

0.71

6.43

1.3

—

(3006462) Nitrate [Presence] in Urine

210

1.95

6.37

3.7

2.1

—

(3033099) Centromere Ab [Titer] in Serum

2.56

6.32

1.1

—

(3000330) Specific gravity of Urine by Test strip

852

3649

1.22

6.29

3.5

3.6

1.02

ratio

1.17

745

3291

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

291

0.30

6.29

1.2

79.06

65.78

ug/l

0.47

291

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

122

374

1.69

6.28

1.2

6.02

5.69

umol/l

0.35

103

342

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

498

2008

1.29

6.23

1.3

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

161

532

1.57

6.19

1.1

—

(3004809) Band form neutrophils/Leukocytes in Blood

305

1146

1.38

6.16

4.0

3.7

1.26

1.59

0.87

268

1006

(3034274) Bile acid [Moles/volume] in Serum --fasting

308

1160

1.38

6.13

2.0

2.3

5.31

6.73

umol/l

1.44

218

877

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

2.45

6.10

2.0

2.3

8.27

7.77

mmol/l

0.20

(3028626) Oxygen [Partial pressure] in Capillary blood

460

1843

1.30

6.06

3.1

3.4

8.15

8.07

kpa

0.43

452

1805

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

137

438

1.62

6.04

5.3

27.13

93.63

u/ml

1.37

143

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

2.45

5.96

1.1

0.09

3.26

u/ml

1.35

(3016650) Hepatitis A virus Ab [Presence] in Serum

316

1202

1.36

5.94

1.2

1.1

—

(4198724) Urine methamphetamine measurement

133

424

1.63

5.93

2.4

2.7

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

206

726

1.47

5.91

1.2

1.1

—

(3036489) Thrombin time

654

2744

1.24

5.90

1.9

2.5

20.74

21.14

0.78

589

2481

(4027681) Cerebrospinal fluid IgG ratio and IgG index

111

338

1.70

5.88

1.3

1.2

0.56

0.89

ratio

1.05

203

(3008295) Osmolality of Serum or Plasma

204

720

1.47

5.82

1.4

1.5

280.77

282.83

mosm/kgh2o

0.49

139

569

(1616796) Gas panel - Central venous blood

444

1790

1.29

5.61

4.1

4.5

—

(3013637) Mi-2 Ab [Presence] in Serum

117

2.21

5.61

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

117

2.21

5.61

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

117

2.21

5.61

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

117

2.21

5.61

1.0

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

2.52

5.61

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.34

5.48

1.0

1.1

—

(3036180) Methadone [Presence] in Urine

7.24

5.48

2.1

4.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

127

409

1.61

5.48

1.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

3.45

5.38

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

204

733

1.44

5.35

1.1

1.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

702

3010

1.21

5.19

1.8

2.0

2.08

2.46

ug/l

0.25

619

2700

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

3.57

5.13

1.5

1.3

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.57

5.13

1.2

1.0

0.02

0.06

u/ml

0.71

(40768793) Breast Pathology biopsy report

252

949

1.38

5.10

1.4

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

123

401

1.59

5.08

1.7

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

949

5697

0.85

4.96

1.5

1.6

977.06

1077.68

mu/l

1.78

778

4974

(3037756) Immunofixation for Serum or Plasma

348

1383

1.31

4.95

1.4

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

288

1.69

4.94

1.5

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

288

1.69

4.94

1.5

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

288

1.69

4.94

1.5

1.9

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

167

1.92

4.91

1.2

10.00

18.96

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

3.03

4.89

1.1

1.71

1.63

umol/24h

0.17

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

256

974

1.36

4.89

1.2

1.6

21.47

10.70

u/ml

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

289

1.68

4.89

1.5

1.9

—

(3020891) Body temperature

676

2911

1.21

4.81

3.9

5.3

36.94

36.91

°c

1.00

663

2873

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

922

4083

1.18

4.80

8.5

11.4

16.16

15.80

3.52

896

3949

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

172

613

1.45

4.76

2.3

3.1

—

(3006270) Folate [Moles/volume] in Blood

143

491

1.51

4.75

1.2

1.1

385.61

343.34

nmol/l

1.36

127

379

(3023419) Bacteria identified in Sputum by Culture

222

830

1.39

4.73

2.5

2.8

—

(3014271) Vancomycin [Susceptibility]

308

1.65

4.71

2.9

3.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

572

2430

1.22

4.68

1.4

1.3

237.94

234.93

miu/ml

0.06

260

1054

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

172

616

1.45

4.65

1.5

1.8

—

(3021901) Oxygen saturation in Capillary blood

399

1632

1.27

4.58

3.0

3.4

89.52

89.48

0.03

389

1592

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

296

1.64

4.51

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

296

1169

1.31

4.45

1.5

1.8

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

2.54

4.42

1.0

37.82

26.12

iu/ml

0.41

(3013005) Retinol [Moles/volume] in Serum or Plasma

247

1.70

4.38

2.0

2.3

1.95

1.92

umol/l

0.16

223

(3003181) Sodium [Moles/volume] in Urine

319

1276

1.30

4.38

1.3

1.4

60.38

60.11

mmol/l

0.04

261

1012

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

182

1.82

4.36

1.1

1.0

8.40

14.34

u/ml

1.31

115

(3006653) Thiamine [Moles/volume] in Blood

260

1.67

4.31

1.4

1.2

133.19

132.76

nmol/l

0.03

260

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

142

1.93

4.31

1.2

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.34

4.27

1.0

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.59

4.25

1.7

1.6

47.70

48.43

umol/l

0.03

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

2.59

4.25

1.0

0.02

0.24

u/ml

1.04

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.33

4.12

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

171

1.82

4.09

1.3

1.2

0.29

0.30

g/l

0.64

139

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

134

1.93

4.08

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

237

919

1.34

4.08

1.8

2.0

4028.57

2388.84

titre

0.18

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

269

1.64

4.04

1.3

1.6

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

269

1.64

4.04

1.3

1.6

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

172

1.81

4.02

1.1

1.2

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

157

1.85

4.02

1.3

1.2

112.59

113.61

0.10

142

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

2.49

3.99

1.0

0.12

1.31

u/ml

0.66

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

110

2.02

3.99

1.1

1.5

9.37

10.35

ug/l

0.64

110

(3006184) Hemoglobin [Mass/volume] in Capillary blood

429

1802

1.24

3.97

2.2

2.6

130.39

127.97

g/l

1.07

328

1515

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

419

0.54

3.95

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

287

1.61

3.94

6.9

7.1

34.79

70.59

ug/l

0.32

201

(3042631) Mycobacterium sp identified in Specimen

224

867

1.34

3.92

2.9

2.6

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

284

1.60

3.89

1.1

1.4

84.89

65.82

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

122

1.95

3.88

1.1

—

(3048879) Bone marrow aspiration report

144

1.87

3.88

1.5

2.0

—

2.00

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

424

1784

1.23

3.87

1.5

1.7

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

502

0.59

3.86

1.1

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

134

476

1.46

3.86

1.4

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

134

476

1.46

3.86

1.4

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

134

476

1.46

3.86

1.4

1.7

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.49

3.84

1.1

0.45

0.38

u/ml

0.11

(3012989) Citrate [Moles/time] in 24 hour Urine

6.46

3.81

1.4

2.1

1.70

1.38

mmol/24h

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

6.46

3.81

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.16

3.81

1.2

1.1

0.71

0.64

umol/24h

0.64

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

2.87

3.80

1.6

1.5

0.84

2.90

mg/l

1.22

(3041806) Other cells [#/volume] in Blood by Manual count

532

0.60

3.79

1.4

0.46

0.53

e9/l

2.24

532

(3024932) HLA-DR beta [Type]

379

0.53

3.77

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

155

569

1.41

3.76

1.5

1.8

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

251

1.63

3.73

1.3

1.2

445.46

242.00

u/l

0.75

240

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

192

1.72

3.72

1.6

2.2

40.60

39.93

g/l

0.33

192

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

121

1.92

3.68

1.1

—

(3024471) HLA-A [Type]

389

0.54

3.67

1.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

334

1.53

3.66

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

114

1.95

3.65

1.1

—

(3020650) Glucose [Presence] in Urine

170

1.77

3.65

1.9

1.4

0.10

0.00

estimate

0.80

170

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

245

1.63

3.63

1.6

1.7

9.68

11.78

nmol/l

0.07

209

(1617658) Protocol used for examination of sentinel lymph nodes

258

1.60

3.58

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

156

1.79

3.57

1.8

2.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.44

3.57

1.0

1.1

1.78

1.71

iu/ml

—

(3051339) Copper [Moles/volume] in Blood

3.73

3.57

1.2

19.09

17.05

umol/l

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

145

532

1.41

3.55

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.81

3.49

1.1

64.00

112.46

titre

1.48

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

209

1.66

3.42

1.1

500.76

222.72

ng/l

0.33

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

112

0.28

3.41

1.7

3.0

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

202

1.67

3.37

1.3

1.5

16.53

15.02

pmol/l

0.44

176

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

230

1.62

3.37

1.1

1.2

—

(3025130) Human papilloma virus identified in Specimen

228

909

1.30

3.31

1.8

—

(3043410) Blood group antigens tested for on Red Blood Cells

188

1.68

3.27

1.3

1.7

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

5.82

3.27

1.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

244

985

1.28

3.24

1.1

1.2

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

2.59

3.21

1.0

1.1

5.87

7.82

u/ml

0.26

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

145

543

1.38

3.20

1.3

76.25

168.55

titre

2.02

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

152

574

1.37

3.19

1.3

1.6

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

166

1.71

3.19

1.3

157.67

129.75

nmol/l

0.40

119

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

149

561

1.38

3.19

1.2

1.4

—

titre

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

423

1820

1.21

3.18

1.5

1.7

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

311

1976

0.81

3.17

4.1

7.8

1323.38

705.20

iu/ml

0.39

356

(3004119) Hemoglobin [Mass/volume] in Venous blood

1033

4766

1.13

3.13

2.8

4.1

131.24

126.52

g/l

8.78

997

4662

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

114

0.32

3.11

1.0

1.05

1.19

mom

—

114

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

2.66

3.05

1.5

0.83

4.18

mg/l

1.99

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

2.66

3.05

1.5

2.77

2.67

mg/l

0.02

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

2.66

3.05

1.5

0.38

0.77

mg/l

0.73

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

2.66

3.05

1.5

3.92

2.18

mg/l

0.38

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

2.66

3.05

1.5

4.38

1.75

mg/l

0.53

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

2.66

3.05

1.5

0.69

2.95

mg/l

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

2.66

3.05

1.5

1.67

2.75

mg/l

0.54

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

2.66

3.05

1.5

0.43

2.86

mg/l

1.45

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

2.66

3.05

1.5

2.90

5.12

mg/l

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

5.17

3.04

1.2

1.0

—

(3040151) Glucose [Moles/volume] in Capillary blood

225

910

1.28

2.98

7.2

17.2

7.12

7.45

mmol/l

0.74

191

762

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

366

1564

1.21

2.97

1.6

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

2.26

2.96

1.0

0.03

0.14

u/ml

1.27

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

231

942

1.27

2.88

1.4

1.7

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

110

401

1.42

2.87

1.3

1.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

216

1.58

2.86

1.6

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

216

1.58

2.86

1.6

2.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

112

410

1.41

2.86

1.3

1.5

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

156

1.69

2.86

1.2

1.1

3.24

66.93

u/ml

0.49

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

127

0.37

2.83

1.6

3.0

23.62

22.61

mg/l

—

122

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

259

0.52

2.82

2.5

1.9

15035.86

13031.81

e6/l

0.09

135

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

307

1297

1.23

2.81

3.0

3.6

1012.73

1123.72

u/ml

0.06

285

1166

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

103

1.86

2.81

2.3

2.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

144

0.36

2.81

1.1

2.3

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.45

2.80

1.0

1.4

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.03

2.80

3.2

3.0

—

(44806420) Estimation of glomerular filtration rate

156

607

1.33

2.76

2.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

317

1347

1.22

2.75

1.3

5.12

4.03

ug/l

0.39

298

1251

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

2.59

2.75

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

151

585

1.34

2.75

1.1

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.18

2.75

1.1

1.2

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

3.98

2.73

1.1

4.4

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

237

977

1.26

2.72

1.1

1.2

118.51

109.57

4.11

215

910

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

131

1.74

2.72

1.0

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

531

2366

1.16

2.72

3.2

3.6

1976.33

1189.97

u/ml

0.23

441

2055

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

110

406

1.40

2.70

1.5

—

(3010503) CD19 cells [#/volume] in Blood

100

364

1.42

2.66

2.2

2.7

199.29

423.98

e6/l

0.50

355

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

106

390

1.41

2.66

1.5

1.6

—

(3044242) Glucose [Moles/volume] in Arterial blood

106

390

1.41

2.66

1.6

2.0

7.56

8.68

mmol/l

1.70

106

390

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.45

2.65

1.1

0.23

0.44

iu/ml

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

296

1.47

2.64

2.2

2.7

47.68

51.82

umol/l

0.59

260

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

143

554

1.34

2.62

1.5

1.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

219

1.54

2.53

1.6

2.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

355

1540

1.19

2.52

1.4

1.5

—

(3018405) Lactate [Moles/volume] in Arterial blood

473

2103

1.17

2.52

3.1

4.5

1.51

mmol/l

0.00

464

2046

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

351

1.42

2.51

1.3

1.4

5.81

5.42

mmol/l

0.84

335

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

274

1.47

2.51

1.4

1.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

300

1282

1.21

2.50

1.4

1.5

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

100

1.81

2.49

1.1

1.2

134.45

100.90

mg/l

0.09

(4195642) Thrombophilia screening test

236

984

1.24

2.49

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

118

448

1.36

2.49

1.5

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

2.25

2.48

1.0

0.03

0.45

u/ml

0.73

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

184

1200

0.79

2.47

2.3

2.5

20.57

31.23

iu/ml

0.93

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.84

2.45

1.2

275.58

465.08

pmol/l

0.54

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

2.02

2.42

1.0

0.02

0.17

u/ml

1.23

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

3.45

2.41

1.0

1.5

—

(3016038) Potassium [Moles/volume] in Urine

120

460

1.35

2.39

1.2

34.45

33.55

mmol/l

0.16

104

411

(3045716) Anion gap in Serum or Plasma by calculation

172

695

1.28

2.37

2.9

3.1

10.33

10.94

mmol/l

1.11

167

688

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

4.14

2.35

1.1

1.0

—

mmol/l

—

(3047189) Immunofixation for 24 hour Urine

274

1.45

2.35

1.7

1.6

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

147

584

1.30

2.31

2.1

2.0

1.65

5.28

u/field

0.47

341

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

298

1287

1.20

2.26

1.4

—

(4133840) Spirometry

143

1.63

2.26

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

268

1.45

2.25

1.1

1.2

20.43

9.39

u/ml

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

140

556

1.30

2.22

1.6

1.4

30.86

35.58

nmol/l

1.18

123

531

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

2.03

2.19

1.3

2.1

—

(40768795) Lymph node Pathology biopsy report

133

526

1.31

2.18

1.2

1.3

—

(4212803) Bone marrow aspirate examination

2.14

2.13

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

162

1.56

2.12

2.2

12.22

17.85

umol/l

3.85

162

(3017569) Oxygen content in Arterial blood

105

403

1.35

2.12

1.9

2.2

16.33

15.78

0.83

105

403

(3051387) C reactive protein [Mass/volume] in Capillary blood

332

1458

1.18

2.12

3.6

2.8

26.21

31.56

mg/l

1.85

231

1025

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

244

1042

1.21

2.11

1.4

1.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

216

911

1.23

2.11

1.5

1.7

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

163

1.55

2.07

2.3

3.5

1.85

1.83

ratio

0.03

146

(3001218) Citrate [Mass/time] in 24 hour Urine

4.02

2.06

1.4

1.8

378.71

303.11

mg/24h

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

335

1476

1.18

2.06

1.7

3.2

0.93

0.82

nmol/l

1.83

276

1249

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

479

2169

1.14

2.06

2.2

3.2

183.89

195.38

1.89

453

2083

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

251

1079

1.20

2.04

1.3

4.61

3.86

u/ml

0.18

113

549

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

231

985

1.21

2.04

5.8

6.9

11.84

11.87

mg/l

0.04

208

916

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

185

771

1.24

2.03

1.1

1.2

98.92

91.26

3.35

173

737

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.45

2.02

1.1

1.0

0.03

0.75

u/ml

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

211

1.47

1.99

1.1

94.59

79.53

1.70

113

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

116

1.65

1.99

2.3

1.9

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

389

1741

1.16

1.98

1.1

1.4

39.22

42.82

u/ml

—

(3001556) Androgen free Index in Serum or Plasma

1.88

1.97

1.3

1.2

—

(3011048) Pyruvate [Moles/volume] in Blood

2.71

1.96

1.5

1.3

88.27

71.86

umol/l

0.38

(3006567) Chloride [Moles/time] in 24 hour Urine

4.43

1.96

1.8

1.3

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

221

1.45

1.93

1.1

1.2

109.77

100.31

1.00

210

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

106

415

1.32

1.91

1.7

1.8

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

188

1.49

1.89

1.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

3.18

1.88

1.1

32.79

31.85

mg/24h

—

(3051101) Glucose [Moles/volume] in Cord blood

174

0.53

1.88

6.7

4.9

7.87

8.62

mmol/l

0.74

174

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

155

1.53

1.87

1.9

2.0

—

(40759632) Porphyrins [Mass/mass] in Stool

5.17

1.86

1.2

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.00

1.86

1.1

1.0

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

356

1.34

1.81

2.1

3.2

784.32

1039.92

u/ml

0.76

349

(3044007) Cell count panel - Peritoneal fluid

237

0.61

1.80

2.1

—

(3011412) CD3 cells [#/volume] in Blood

146

602

1.26

1.80

2.2

2.4

1332.34

1065.65

e6/l

2.19

124

521

(3012565) Volume of 24 hour Urine

326

1.35

1.78

2.3

2.4

2024.71

1783.04

1.33

290

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

3.88

1.78

1.2

1.0

—

(3029612) Listeria sp Ab [Titer] in Serum

3.88

1.78

1.5

1.3

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

344

1.34

1.77

1.8

1.5

659195.50

1092786.17

iu/ml

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

114

457

1.29

1.76

1.7

1.8

4.28

5.04

mg/l

0.85

107

437

(3023487) Leukocytes [#/volume] in Peritoneal fluid

292

0.65

1.75

2.1

3907.18

2771.14

e6/l

0.12

198

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

170

0.55

1.75

3.1

3.0

325.44

63.69

ug/l

0.38

170

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

257

1126

1.18

1.75

1.2

1.3

2.77

4.34

u/ml

0.79

445

(3045142) Bone marrow Pathology biopsy report

170

716

1.23

1.74

1.2

1.4

—

(3000060) B lymphocytes [#/volume] in Blood

175

1.48

1.73

1.7

2.0

0.17

0.66

e9/l

0.43

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.38

1.73

2.0

3.4

—

(40762887) Creatinine [Moles/volume] in Blood

2.72

1.73

1.9

1.3

—

(3001729) Color of Synovial fluid

2.19

1.70

1.9

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

169

714

1.23

1.69

1.1

1.2

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

156

654

1.23

1.68

1.4

1.3

1.60

1.43

nmol/l

0.90

141

593

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

294

1.35

1.68

2.1

2.0

37.50

142.95

ug/min

1.93

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

106

1.61

1.66

1.1

1.3

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

4.31

1.66

1.0

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

104

416

1.29

1.65

2.0

2.7

207.48

238.60

e6/l

0.63

336

(3010015) Selenium [Moles/volume] in Serum or Plasma

1.81

1.64

2.1

1.8

1.21

1.31

umol/l

0.60

(3004451) EKG impression Narrative

376

1.31

1.64

1.2

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

338

1523

1.15

1.63

1.6

1.7

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

329

1480

1.15

1.63

1.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

147

616

1.23

1.61

1.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

350

2057

0.88

1.58

4.7

3.9

—

(3004775) Volume in Urine collected for unspecified duration

114

738

0.80

1.56

2.0

2.7

607.80

674.16

1.06

528

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

214

1.40

1.56

1.1

97.28

81.59

2.93

113

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.17

1.55

1.1

1.0

—

(3017704) Immunofixation for Urine

380

1.29

1.53

1.3

1.6

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.46

1.53

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.22

1.50

1.0

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.78

1.49

1.0

10.59

1.61

u/ml

—

(3041184) Isoniazid [Presence] in Urine

3.69

1.49

1.8

2.9

—

(21494434) Karyotype in Bone marrow

137

576

1.23

1.48

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

156

666

1.21

1.46

3.3

3.8

13.71

13.47

index

0.07

412

(3033942) Copper [Moles/time] in 24 hour Urine

2.27

1.46

1.0

1.3

0.24

1.98

umol/24h

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

132

833

0.82

1.45

1.4

1.7

—

(3038515) Glucose [Moles/volume] in Venous blood

312

1834

0.88

1.44

3.5

7.27

7.95

mmol/l

3.46

298

1804

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.70

1.43

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

335

1.30

1.41

4.1

3.7

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.14

1.40

1.1

1.0

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

364

1670

1.13

1.39

1.1

1.4

256.56

265.21

u/ml

0.22

229

1135

(3038071) Oxygen [Partial pressure] in Mixed venous blood

183

0.62

1.38

9.0

11.0

5.75

5.97

kpa

0.18

183

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

1.65

1.37

1.0

0.02

0.05

u/ml

0.46

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.65

1.37

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

305

1.31

1.37

6.5

8.5

45.75

10574.92

u/ml

0.72

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

1.88

1.36

1.4

1.8

20.76

21.58

mmol/l

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.88

1.36

1.5

2.3

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

329

0.72

1.35

7.0

6.4

8.93

9.16

0.09

329

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

267

1203

1.15

1.35

1.1

88.11

925.08

iu/ml

0.54

231

(40768441) Liver Pathology biopsy report

108

448

1.25

1.34

1.6

1.4

—

(3028714) Urate [Moles/time] in 24 hour Urine

3.23

1.34

1.4

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

167

725

1.19

1.34

1.3

1.5

8.66

7.97

mmol/l

1.42

160

703

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

329

1.29

1.33

1.0

37.39

43.43

ng/l

0.74

236

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

329

1.29

1.33

1.0

803.08

708.07

ng/l

1.04

229

(40761995) Spermatozoa Progressive [#/volume] in Semen

328

0.72

1.33

3.5

3.2

48.72

44.45

0.73

328

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

398

1.26

1.33

2.2

2.8

0.84

0.56

e9/l

1.94

384

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.72

1.32

1.0

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.65

1.32

1.3

1.2

—

(3033086) Enterovirus Ab [Titer] in Serum

2.22

1.32

1.0

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

226

1009

1.16

1.30

1.2

1.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

355

1637

1.12

1.27

2.9

2.6

37.38

31.94

umol/l

1.19

321

1476

(3002331) Protein [Mass/volume] in Peritoneal fluid

191

0.65

1.26

1.1

1.4

26.93

111.13

g/l

0.49

161

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

346

1.27

1.25

1.1

1.2

93.12

91.46

u/l

0.04

306

(3022493) Free Hemoglobin [Mass/volume] in Plasma

436

0.77

1.25

1.2

7.6

62.79

897.81

mg/l

0.84

333

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

130

807

0.83

1.25

1.5

1.7

8.27

7.44

mmol/l

2.33

124

763

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

262

1539

0.88

1.24

2.0

3.7

865.00

8249.26

u/ml

0.69

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

412

1.24

1.22

2.1

2.6

612.39

502.95

e6/l

0.51

320

(3043409) Potassium [Moles/volume] in Arterial blood

373

1730

1.12

1.22

3.4

5.0

3.90

3.93

mmol/l

0.39

366

1707

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

325

1.27

1.21

1.0

275.73

332.57

ng/l

1.14

236

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.87

1.20

1.2

3.0

29.10

42.29

umol/24h

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

367

1.25

1.20

1.5

1.6

6.95

7.64

u/l

0.17

288

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

195

1.35

1.18

1.1

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

154

673

1.18

2.0

1.8

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

151

1.40

1.18

1.1

1.4

—

(3009677) Dengue virus Ab [Presence] in Serum

2.18

1.17

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.03

1.16

1.2

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

196

1.35

1.15

1.2

1.3

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

205

1.34

1.15

2.4

3.1

27.77

29.41

umol/l

0.47

150

(3020876) Protein [Mass/time] in 24 hour Urine

216

973

1.15

1.14

2.2

2.5

1.04

1.25

g/24h

0.66

124

643

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

342

1.26

1.14

1.1

1.2

32.35

28.32

u/l

0.15

302

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

109

1.47

1.13

2.8

2.3

93.73

90.19

ng/l

0.04

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

496

2349

1.09

1.11

2.1

2.8

92.66

91.88

0.31

481

2282

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

279

1.28

1.10

2.9

2.8

116.31

124.07

au/ml

0.06

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

390

1.23

1.10

1.1

1.2

1.04

1.07

ratio

1.98

331

(3018001) Oat IgE Ab [Units/volume] in Serum

1.81

1.10

1.0

1.1

0.25

0.30

u/ml

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.11

1.09

1.1

204.92

213.59

nmol/l

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.66

1.08

1.0

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.52

1.07

1.0

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.45

1.07

3.2

2.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

152

671

1.17

1.06

1.1

1.2

64.21

67.78

u/l

0.17

142

605

(3018834) Bilirubin.total [Presence] in Urine by Test strip

2.02

1.06

1.2

3.8

—

0.00

estimate

—

(3000012) Reticulocyte production index

251

1150

1.13

1.05

2.2

2.1

0.90

0.88

0.21

177

804

(3017509) Phencyclidine [Presence] in Urine

1.48

1.05

1.6

2.5

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.55

1.04

2.4

3.4

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.72

1.02

1.2

1.1

16.53

6.73

u/l

1.00

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

1.00

0.0

1.2

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.90

0.99

1.0

0.04

0.11

u/ml

0.32

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

204

0.71

0.98

7.9

10.6

5.87

5.85

kpa

0.05

183

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

336

1.23

0.96

1.8

2.88

3.40

u/field

0.22

245

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

1.52

0.95

1.1

1.2

0.24

0.21

nmol/l

0.17

(3042111) Morphology [Interpretation] in Bone marrow Narrative

242

1115

1.12

0.95

1.5

1.7

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

412

1.21

0.95

1.1

1.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

512

2450

1.08

0.94

2.4

3.0

3.60

3.58

g/l

0.12

483

2353

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

2.07

0.93

1.1

1.0

8.78

8.58

mmol/l

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

385

1.21

0.92

1.1

1497.61

1514.98

miu/ml

0.05

385

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.21

0.92

1.0

1.1

5.67

2.93

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

381

0.80

0.90

2.4

2.8

0.63

0.61

mmol/l

1.32

381

(1175426) CD3 cells/Lymphocytes in Blood

113

497

1.18

0.87

2.0

1.9

73.15

72.76

0.09

106

479

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

109

478

1.18

0.87

2.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

197

1.29

0.87

1.1

—

12.20

—

(40765096) Chromosome analysis panel by Banding

152

1.33

0.86

1.2

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

152

1.33

0.86

1.2

62.57

78.84

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.59

0.85

1.0

1.1

6.40

11.62

iu/ml

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

668

3670

0.94

0.85

3.3

4.3

25.23

24.94

mmol/l

1.31

636

3547

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.50

0.84

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

125

0.66

0.84

9.4

7.4

10.49

10.51

0.01

125

(3000034) Microalbumin [Mass/volume] in Urine

129

576

1.16

0.84

2.7

3.2

26.65

74.62

mg/l

2.26

416

(3047181) Lactate [Moles/volume] in Blood

447

2141

1.08

0.83

4.8

6.3

1.32

1.33

mmol/l

0.13

397

1910

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.51

0.83

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.50

0.82

1.8

1.3

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.48

0.79

2.4

2.6

0.75

0.44

u/field

0.74

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.61

0.78

1.4

1.3

—

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

1.49

0.78

1.3

1.2

0.94

0.88

ml/s/173m2

0.10

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.49

0.78

1.3

1.2

—

(37021550) Renin [Units/volume] in Plasma --upright

1.40

0.78

1.6

1.4

95.47

92.40

mu/l

0.03

(3020393) Adenovirus Ag [Presence] in Stool

1.50

0.77

1.0

1.1

—

(3028433) Virus identified in Specimen by Culture

174

1.28

0.75

1.5

1.2

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.66

0.74

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

1.55

0.74

1.0

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

348

0.82

0.74

3.6

3.4

1.38

1.06

0.51

348

(3008152) Bicarbonate [Moles/volume] in Arterial blood

891

4387

1.05

0.73

5.5

7.4

24.30

mmol/l

0.00

853

4193

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

210

979

1.11

0.73

2.7

2.9

131.94

1466.72

u/ml

1.12

204

966

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

152

1.29

0.73

1.1

1.2

72.83

83.02

—

(40757494) Bilirubin.total [Moles/volume] in Blood

287

1.21

0.72

1.8

2.1

8.09

24.88

umol/l

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.63

0.71

1.0

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

209

0.77

0.71

7.5

6.7

67.17

70.68

0.32

170

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.62

0.70

1.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

341

1.18

0.69

1.1

1.3

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

322

1.19

0.69

3.3

3.6

7.21

9.49

mg/l

2.24

265

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.41

0.69

1.0

1.6

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

1.45

0.68

1.3

129.00

105.39

ug/l

—

(4268621) Lupus anticoagulant assay

167

773

1.12

0.68

2.4

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

386

1.17

0.66

4.4

3.5

24.92

68.79

u/ml

3.01

376

(3029634) Reagin Ab [Titer] in Serum by VDRL

259

1229

1.09

0.65

2.5

2.4

5.29

5.68

titre

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

1.72

0.65

1.1

1.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.49

0.64

1.0

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

222

1.21

0.61

1.2

1.5

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

1.82

0.60

6.3

8.5

5.65

10.65

mg/l

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.56

0.59

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.42

0.59

1.1

2.3

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.54

0.58

1.0

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

174

816

1.10

0.58

1.4

6.12

6.49

mmol/l

0.69

158

772

(4034850) Laboratory test

386

1873

1.07

0.57

12.4

10.1

—

(3016750) Collection duration of Urine

530

0.88

0.56

1.7

2.8

482.95

503.19

min

1.05

434

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

136

631

1.11

0.56

1.3

15.66

14.23

u/l

0.23

126

572

(3026051) Granulocytes/Leukocytes in Pleural fluid

182

1.22

0.56

1.3

1.4

26.63

20.74

0.74

143

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

166

0.78

0.55

2.6

2.0

1.18

1.19

mmol/l

0.22

159

(3019832) Treponema pallidum Ab [Presence] in Serum

2110

10640

1.03

0.55

1.9

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

336

1626

1.07

0.55

2.2

2.8

109.36

111.01

ug/min

0.02

205

1028

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.58

0.54

1.7

1.3

—

(3019174) dRVVT (LA screen)

1.45

0.54

1.1

1.2

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

770

3816

1.04

0.54

3.7

4.7

47.35

46.82

0.23

750

3759

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

1.40

0.53

1.2

1.0

38.14

50.76

mg/l

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.38

0.49

1.1

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

115

1.26

0.48

1.1

1.3

1068.62

77.79

u/l

0.46

(3007930) Methemoglobin/Hemoglobin.total in Blood

594

3206

0.96

0.48

4.5

5.4

0.82

0.87

2.07

570

3057

(3008037) Lactate [Moles/volume] in Venous blood

383

2090

0.95

0.48

3.3

1.52

1.72

mmol/l

4.18

368

2051

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

253

1.16

0.47

1.1

98.74

94.15

0.53

211

(40757373) Influenza virus identified in Isolate

190

0.82

0.46

1.3

1.6

—

(3005033) Fetal Nuchal fold Thickness US

437

2373

0.95

0.46

1.5

1.25

0.05

301

1770

(3029396) Erythrocyte agglutination [Presence] in Blood

329

0.86

0.46

2.8

3.5

—

(3006245) CD3-CD19+ cells/cells in Blood

259

1.16

0.45

2.1

2.0

8.11

10.22

0.65

235

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.46

0.45

1.0

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

226

1.17

0.44

1.4

1.3

977.19

37.72

ug/l

1.02

109

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.61

0.43

1.4

1.0

2.96

0.62

u/ml

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

1.26

0.42

1.7

2.0

2.46

2.77

ug/l

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

449

2429

0.95

0.42

1.5

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.33

0.42

1.4

—

(40758292) HTLV I+II Ab panel - Serum

127

1.22

0.42

1.2

1.4

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

193

0.83

0.42

1.1

1.2

6.93

12.70

pmol/l

1.86

(3027923) C peptide [Moles/volume] in Serum or Plasma

383

1.12

0.42

1.5

1.13

1.20

nmol/l

0.22

306

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.42

0.0

1.0

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

1.52

0.41

1.2

1.1

7.02

7.82

kpa

—

(3006598) pH of Arterial cord blood

1.52

0.41

1.2

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

1.28

0.40

1.5

1.7

1.89

1.06

mmol/l

0.34

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

172

826

1.08

0.39

1.3

558.48

493.44

u/l

0.10

160

782

(3028717) Thiamine [Mass/volume] in Blood

1.25

0.38

1.2

65.36

64.29

ug/l

0.08

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

110

1.22

0.37

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.74

0.37

2.6

2.4

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

134

1.20

0.37

1.0

1.3

—

12.38

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

221

1211

0.94

0.36

1.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

0.78

0.34

1.3

1.4

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

140

1.18

0.34

1.1

1.3

0.82

1.30

mmol/l

0.37

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

127

0.81

0.34

1.1

1.5

8875.00

25020.83

u/ml

—

(3009871) Measles virus Ab [Titer] in Serum

242

1.13

0.34

1.7

1.5

2640.00

3053.71

titre

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

585

2922

1.04

0.34

1.5

1.6

56.33

65.48

ug/l

4.85

474

2447

(4038314) Semen analysis, post vasectomy

1.26

0.33

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

112

1.20

0.33

1.2

1.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

248

0.87

0.33

3.5

3.1

11.03

10.37

kpa

0.69

248

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

248

0.87

0.33

3.5

3.1

4.60

4.94

kpa

1.82

248

(3041918) Cholesterol [Moles/volume] in Pleural fluid

160

1.16

0.33

1.2

1.3

1.54

1.41

mmol/l

0.24

(3028308) Erythrocytes [#/volume] in Pleural fluid

190

925

1.06

0.32

1.5

1.4

90676.65

43876.12

e6/l

0.69

109

522

(3016031) Almond IgE Ab [Units/volume] in Serum

1.35

0.32

1.0

0.26

0.38

u/ml

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

410

0.91

0.32

2.7

2.8

42.49

38.60

0.78

212

(3023199) Leukocytes [#/volume] in Pleural fluid

213

1042

1.06

0.31

1.5

1776.46

1607.93

e6/l

0.22

149

736

(46235168) Fasting glucose [Moles/volume] in Blood

108

1.20

0.31

1.2

3.3

8.44

7.43

mmol/l

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

142

0.84

0.31

1.7

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

252

0.88

0.31

1.4

1.7

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

1.32

0.31

1.1

26.94

19.22

u/ml

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.77

0.30

1.5

—

(3018572) Chloride [Moles/volume] in Blood

277

1496

0.96

0.29

5.8

7.4

105.15

104.95

mmol/l

0.32

254

1368

(3039000) Anion gap in Blood by calculation

277

1496

0.96

0.29

5.8

7.4

11.65

11.35

mmol/l

0.82

254

1368

(3043238) Trisomy 21 risk [Likelihood] in Fetus

461

2462

0.97

0.28

1.6

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.26

0.26

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.26

0.26

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.22

0.26

1.0

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

297

1.10

0.26

1.6

1.5

58.40

65.98

0.79

238

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

267

1437

0.96

0.25

1.8

1.7

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

140

1.14

0.25

1.1

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

467

2485

0.97

0.24

2.5

4.4

1.63

1.73

mg/l

1.27

422

2294

(44806118) Parainfluenza type 4 nucleic acid detection

191

941

1.05

0.24

1.4

1.6

—

(40758358) Immune stain study

1.36

0.24

1.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

175

1.12

0.24

1.7

1.3

0.30

0.29

mmol/l

—

(44790048) Parainfluenza type 2 nucleic acid detection

191

942

1.05

0.23

1.4

1.6

—

(44790049) Parainfluenza type 3 nucleic acid detection

191

942

1.05

0.23

1.4

1.6

—

(44790047) Parainfluenza type 1 nucleic acid detection

191

942

1.05

0.23

1.4

1.6

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.20

0.23

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

391

0.92

0.23

1.1

1.3

984.62

902.22

titre

0.20

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

404

1.07

0.23

1.1

1.3

107.75

102.44

u/l

0.13

361

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.22

0.0

1.2

—

37.00

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.26

0.22

1.0

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

0.22

0.0

1.0

—

35.57

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

314

1676

0.97

0.21

1.2

1.7

150.46

149.09

au/ml

0.07

479

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.77

0.21

1.3

1.2

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

141

0.88

0.20

1.9

1.5

4.75

15.08

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

192

953

1.04

0.20

1.3

1.4

7.38

6.89

mmol/l

1.35

169

821

(3041672) Baker's yeast Ab [Presence] in Serum

1.26

0.19

1.0

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

351

1763

1.03

0.19

1.2

1.7

18.57

20.41

u/ml

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.25

0.19

1.6

1.5

476.31

417.09

nmol/l

—

(3014891) Appearance of Pleural fluid

134

1.12

0.18

1.5

1.6

—

(3044009) aPTT.lupus sensitive (LA screen)

1.22

0.18

1.1

1.2

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

263

0.92

0.17

1.7

1.5

1.08

2.49

1.94

219

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.72

0.17

1.2

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.22

0.17

1.1

1.2

—

(4281824) Cell count and differential, peritoneal fluid

111

602

0.95

0.17

1.2

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

140

1.11

0.16

1.2

1.6

38.38

86.61

ng/l

1.29

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

446

1.05

0.16

1.3

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.17

0.15

1.8

1.6

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

124

667

0.96

0.15

1.8

2.0

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

572

2906

1.02

0.14

2.7

3.5

0.36

0.34

iu/ml

0.60

310

1592

(44786800) Granulocytes/Leukocytes in Body fluid

102

1.11

0.13

1.4

27.87

23.96

0.16

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.83

0.13

1.2

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

0.83

0.13

1.0

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

491

0.96

0.13

2.0

2.2

230.31

189.61

pmol/l

0.08

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.15

0.12

4.7

5.6

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.87

0.12

2.5

2.1

0.53

0.73

ug/l

1.60

(44806071) Cardiolipin IgM antibody measurement

1.12

0.12

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

1.11

0.12

1.5

1.2

19.64

20.21

u/l

0.04

(3006576) Bicarbonate [Moles/volume] in Blood

273

0.95

0.11

5.8

7.1

24.51

24.79

mmol/l

0.22

250

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

446

0.96

0.10

1.1

1.3

—

(3035880) pH of Pleural fluid

470

1.03

0.09

1.4

7.38

7.41

0.73

334

(3008536) Aspergillus sp Ab [Presence] in Serum

145

1.07

0.09

1.4

2.9

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

1.03

0.08

1.5

1.8

0.85

0.67

umol/l

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

107

569

0.97

0.08

1.3

1.4

12.56

13.85

umol/l

0.94

543

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.13

0.08

1.0

—

(3003434) Protein [Mass/volume] in Pleural fluid

236

1198

1.02

0.08

1.5

31.28

30.49

g/l

0.44

212

1066

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.14

0.08

3.0

5.5

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

395

1.03

0.08

1.2

1.3

27.32

27.30

u/l

0.00

351

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

107

539

1.03

0.07

1.4

1.9

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

290

0.96

0.07

2.3

2.0

3763.70

38960.36

u/ml

—

(40768806) Pleura Pathology biopsy report

175

889

1.02

0.06

1.6

1.5

—

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

1.11

0.06

1.5

2.6

19.67

15.89

—

(3045788) Cell count panel - Pleural fluid

167

849

1.02

0.06

1.4

1.5

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

330

1723

0.99

0.05

3.0

3.4

0.86

0.81

nmol/l

0.73

254

1363

(3045462) Protein/Creatinine [Ratio] in Urine

0.93

0.05

2.6

2.9

16.63

45.85

mg/mmol

1.71

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

381

0.98

0.04

1.8

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

381

0.98

0.04

1.8

1.5

—

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

0.93

0.03

1.5

2.6

57.71

63.45

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

342

1780

0.99

0.03

1.2

1.7

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

528

2743

0.99

0.03

1.5

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.95

0.03

1.9

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

0.92

0.02

1.0

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

540

2802

1.00

0.02

1.5

1.19

ratio

0.02

321

1658

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

540

2802

1.00

0.02

1.5

0.95

0.94

ratio

0.24

320

1638

(40765089) Chromosome analysis panel - Blood by G-banded

382

1.01

0.02

1.0

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

118

615

0.99

0.01

10.3

15.3

0.57

0.65

mmol/l

3.78

107

577

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.95

0.01

1.4

5.75

5.55

mmol/l

0.34

(3034988) Calcium [Moles/volume] in Capillary blood

146

1.03

0.01

2.4

1.9

1.19

1.17

mmol/l

0.86

139

(3034426) Prothrombin time (PT)

226

0.98

0.01

1.3

28.49

28.82

0.17

226

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.94

0.00

1.3

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

540

2794

1.00

0.00

1.5

1.15

1.19

ratio

0.30

320

1631

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

666

3438

1.00

0.00

4.4

5.2

1.64

1.60

0.45

639

3281

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

168

865

1.00

0.00

1.7

1.8

21.15

26.56

ug/l

1.25

163

837

(3032868) Hemoglobin electrophoresis panel in Blood

0.98

0.00

1.1

1.6

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.01

0.00

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

245

1269

1.00

0.00

4.9

6.2

326.64

376.75

umol/l

6.32

210

1145

(3052592) Norovirus Ag [Presence] in Stool

145

1.00

0.00

1.4

1.6

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.01

0.00

1.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

199

1.01

0.00

1.2

1.7

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.03

0.00

1.0

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.98

-0.00

1.0

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3022475) Manganese [Moles/volume] in Blood

0.97

-0.00

1.5

1.2

0.15

0.16

umol/l

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

0.86

-0.00

1.0

—

(3022229) Phosphate [Moles/volume] in Urine

0.93

-0.00

1.0

1.2

20.64

18.27

mmol/l

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

244.00

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.90

-0.00

1.9

1.4

—

(40760512) CD34 cells/cells in Bone marrow

0.00

-0.00

0.0

1.0

—

(3021993) C3 nephritic factor [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.97

-0.00

1.0

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.92

-0.00

4.0

11.8

—

(3009992) Blasts/cells in Bone marrow

0.00

-0.00

0.0

1.4

—

25.00

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: RX_ACETICDERIV – Acetic acid derivatives and related substances

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Acetic acid derivatives and related substances

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Acetic acid derivatives and related substances (RX_ACETICDERIV)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints